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A STUDY OF AUDITORY BRAINSTEM RESPONSE AND 
OXIDATIVE STRESS IN INDIVIDUALS WITH VITILIGO 
                                                                                                                                       
                                                               ABSRACT  
                               Introduction: Vitiligo is an idiopathic, acquired, hypomelanotic, 
systemic disorder, affecting the whole pigmentary system including the stria 
vascularis of the inner ear, characterized by depigmented patches of different sizes 
and shapes in the skin resulting from the loss of functional melanocytes and melanin 
from the epidermis. Vitiligo occurs worldwide with a prevalence of 0.1%  to 0.2 %. In 
India, the  prevalence is 3% to 4%. Vitiligo commonly begins in childhood or young 
adulthood, with peak onset of age being 10 to 30 years, but it may occur at any age. 
All races are affected. Both gender are equally affected. Approximately 20% of 
individuals with vitiligo have atleast one first degree relative with vitiligo. The 
etiology of vitiligo is still not known, but several theories have been proposed              
to explain the melanocyte destruction like genetic, neural, cytotoxic and auto-     
immune theories. Oxidative stress has been implemented in the pathophysiology of          
vitiligo. During oxidative stress, the molecular oxygen is reduced to form super-    
oxide radicals. Further, superoxide radicals dismutate to hydrogen peroxide, either 
spontaneously or by the action of superoxide dismutase. Aim  of  the  study  was  (1) 
To evaluate the  conduction  in  the  auditory  pathway in  vitiligo  subjects.  (2) To 
study the role of oxidative stress in vitiligo subjects. Objectives of the study were                                                   
(1) To  evaluate  the  audiological  abnormalities  using  Brainstem  Evoked  Auditory 
Response as a tool  in  individuals  with  vitiligo.(2) To  study  the  role  of  oxidative  
stress  by  assay of  superoxide  dismutase  enzyme  level  in  individuals  with  
vitiligo.  (3) To  do  a  comparative  study  in  a  healthy  control  group.  Materials 
and methods:Ethical approval from Institutional Ethical Committee, Stanley Medical 
College, Chennai-1 was obtained for the study. In this study,  Brainstem Auditory 
Evoked Potential (BAEP) was recorded in 40 individuals affected by vitiligo of 
various dermatomes and distribution, recruited from the Department of Dermatology 
and Department of Cosmetology, Stanley  Medical  College,  Chennai-1, who fulfilled 
the selection criteria. 40 age and gender matched healthy individuals were taken  as  
controls. BAEP recording was done in the Neurophysiology Laboratory of Research 
Wing, Department of Physiology, Government Stanley Medical College, using Neuro 
Perfect Plus – Medicaid Polyrite Hardware – Solokrafts Industries India. Brainstem 
Auditory Evoked Potential of both the ears  were tested. Absolute wave and Inter Peak 
Latencies were measured. Under strict aseptic precautions, venous blood samples 
were collected from both the vitiligo individuals and controls, for estimation of 
superoxide dismutase (SOD) enzyme  level  using ELISA kit in the laboratory. 
Results: A significant increase in the Absolute wave latency III (P < 0.01) of left ear 
was found. There was prolonged Absolute wave latency III of right ear (P = 0.001)  
and prolonged Inter Peak Latency I-III (P < 0.001) of  both the ears and they were 
highly significant when compared with that of the controls. A decrease in the serum 
superoxide dismutase level was noted when compared with that of the controls, but it 
was not statistically significant. Conclusion: Audiological changes in vitiligo subjects 
confirm that the vitiligo represents a systemic disease with widespread involvement of 
body melanocytes. The reduced levels or reduced activities of these melanocytes or 
both may be the cause for audiological abnormalities. Also, the antioxidant level was 
decreased in vitiligo subjects when compared with that of the controls  suggesting a 
state of oxidative stress in them. 
Keywords:  Brainstem Evoked Response Audiometry, Brainstem Auditory Evoked 
Potential,  Vitiligo,  Superoxide dismutase enzyme,  Oxidative stress. 
 
  
 
 
 
1. INTRODUCTION 
Vitiligo is an  idiopathic, acquired, hypomelanotic, systemic  disorder, 
affecting the whole pigmentary system including the stria vascularis  of inner 
ear, characterized by depigmented patches of different sizes and shapes in the 
skin resulting from the loss of functional  melanocytes and melanin from the   
epidermis. Vitiligo occurs worldwide with a prevalence of 0.1% to 0.2 %. In 
India,   the prevalence is 3% to 4%. Vitiligo commonly begins in childhood or 
young adulthood, with peak onset of age being 10 to 30 years, but it may occur 
at any age.   All races are affected. Both gender are equally affected. 
Approximately 20%   of  individuals  with  vitiligo  have  atleast  one  first  
degree relative  with  vitiligo.  
The etiology of vitiligo is still not known but several theories have been 
proposed to explain the melanocyte destruction like genetic, neural, cytotoxic 
and autoimmune theories. Oxidative stress is  thought  to  be  the  initial  
pathogenic  event  in  melanocyte  destruction 72,73. Normally  free  radicals  
such  as  superoxide,  hydrogen  peroxide and  nitric  oxide  are  formed  during  
several  physiological  and  pathological  processes 94. They  are  continuously  
scavenged  by  antioxidant  enzymes  such  as  superoxide  dismutase,  catalase,  
glutathione  peroxidase etc.  During oxidative stress, the molecular oxygen is 
reduced to form superoxide radicals.  Further, superoxide radicals dismutate to 
hydrogen peroxide either spontaneously or by the action of superoxide 
dismutase70,71. The   enzyme catalase converts H2O2 to O2 and water. In  case  
  
 
 
 
of  oxidative  stress,  to  scavenge  or  counteract  the  increased  levels  of  
superoxide anions (O2-),   there   is  an  increase  in  the  levels  of  SOD, an  
antioxidant  enzyme,  whereas  the  catalase  levels  are  decreased 56. The  
formed  H2O2  readily crosses  the  cell  membranes  and can cause  much  of  
the  damage.   
Several studies suggest that the accumulation of free radicals which are 
toxic to melanocytes may lead to their destruction. The  inherent  capacity  of  
cells  to  withstand  the  oxidative  stress  is  due  to  their  ability  to  repair  
oxidatively  modified  biomolecules,  their  antioxidant  ability  and  their  
capacity  to  sustain   metabolic   requirements   by   deriving   energy   from  
alternate   pathways. 
 Several  studies  have  been  done  in  vitiligo  subjects on various  
biomarkers  such  as  superoxide  dismutase (SOD),  catalase (CAT),  
glutathione  peroxidase (GPx)  and  nitric  oxide (NO).  Different results were   
reported about the levels  of  these  biomarkers.  A  few  studies  have  reported   
an  increase  in  the  serum SOD  levels,  few others  have  observed  a  
reduction  in  the  SOD  levels  while  some  studies   have  observed  no  
change  in  the  blood  levels  of  SOD.  Hence, this  study  was  undertaken  to  
assess   the  oxidative  stress  in  vitiligo  subjects  by  estimating  the  levels  of  
SOD  in  the  blood.  This  will  enable us  to  suggest  the  use of  antioxidants  
as  an  adjuvant  in  the  management  of  vitiligo.  
  
 
 
 
The mechanism destroying the melanocyte in the skin could    also 
affect other melanocyte organs5. Several ocular6 and audiological abnormalities 
of hearing7-13 and  brainstem responses(BAERs)10-12 have been reported. The  
purpose  of  this  study  was  to  detect  the  subclinical  audiological  changes  
in  patients  with  vitiligo.  These  patients  are  usually  asymptomatic.  Hence,   
physiological  testing  of   the   function   of   the   eighth   cranial   nerve   may  
provide   sensitive,  quantitative    measures   of   mild   or   early   damage   to  
its   peripheral   or   central   components 46.  Hence,  this  study  was  
undertaken   in  subjects  with  vitiligo  with  the  aim     
                           1. To evaluate the audiological abnormalities using Brainstem 
Evoked  Response  Audiometry as  a  tool .       
                               2.  To assess the oxidative stress by assay of serum 
superoxide dismutase enzyme level.                                          
  
 
 
  
  
 
 
 
                                2.  REVIEW OF LITERATURE  
Vitiligo denotes an acquired, idiopathic, usually progressive, 
circumscribed achromic macules. It is often associated with leukotrichia. 
Histologically it is characterised by degeneration and disappearance of 
melanocytes in the involved skin and not infrequently in the pigment 
epithelium of the inner ear and  pigment  epithelium   of  eyes1.  
2.1.1   CLINICAL PRESENTATION  
a) Focal vitligo : Solitary macule or a few scattered macules in one area most 
commonly in the trigeminal area. 
B) Segmental vitiligo : Unilateral macules in a dermatomal or quasi – 
dermatomal distribution. 
c) Acrofacial  vitiligo :  Depigmentation  of  distal  fingers , toes  and  
periorificial  areas. 
d) Mucosal vitiligo : Involvement of mucosal membrane sites only. 
e) Generalized vitiligo : Also called vitiligo vulgaris. It is the most common 
pattern. Depigmented patches are widely and usually symmetrically distributed. 
f) Universal vitiligo : Depigmented patches over most of the body often 
associated with multiple endocrinopathy syndrome. 
                         
 
  
 
 
 
Diagnosis of vitiligo is primarily based on clinical examination. Since it 
is of autoimmune  in  origin , investigations  may  be  done  to  rule  out  other 
endocrine  disorders. The prognosis and course of vitiligo are unpredictable. 
Initial clinical subtype does not predict future anatomical sites of involvement 
or activity of  the disease2.                
2.1.2     EPIDEMIOLOGY    
Vitiligo affects all the races the world over. Higher incidence has been       
reported in India and Mexico. In India, it is roughly estimated to be 3% - 4%.  
Prevalence is high in the states of Gujarat and Rajasthan in India. Several other 
studies have reported the incidence of 0.1% - 2 % in different parts of the 
globe. Vitiligo  commonly begins in childhood or  young  adulthood .  The  
peak onset  of  age  being  10  to  30  years,  but  it  can  occur  at  any  age 1,20. 
 All races are affected. The incidence among the gender follows the     
general population pattern without any particular predilection. Some reports of    
female preponderance probably reflect their great concern for cosmetic 
disfigurement and related to the social and marital problems. 
 Vitiligo mostly affects people with skin types III and IV. A higher 
incidence has been reported in patients with atopic dermatitis. 
Onset of unilateral dermatomal type is usually in childhood within 10 
years of age. Bilateral non- dermatomal lesions begin in the second to fourth 
decades of life. Onset at the extremes of age is less common1,20. 
  
 
 
 
Fitzpatrick Classification Scale 
Updated in November 25, 2014. The Fitzpatrick Classification Scale was 
developed in 1975 by Harvard Medical School dermatologist, Thomas 
Fitzpatrick, MD, PhD. It is used by many practitioners to determine the way 
one will respond or react to facial treatments  and  his  risk  of  getting  skin 
cancer.  
 This  scale  classifies  a  person's  complexion  and  their  tolerance  of  
sunlight.  
                                                            Table  1 
 
 
Skin 
Type 
Skin Color Characteristics 
I 
White; very fair; red or blond hair; blue 
eyes; freckles 
Always burns, never tans 
II 
White; fair; red or blond hair; blue, 
hazel, or green eyes 
Usually burns, tans with 
difficulty 
III 
Cream white; fair with any eye or hair 
colour; very common 
Sometimes mild burn, 
gradually tans 
IV 
Brown; typical Mediterranean 
caucasian skin 
Rarely burns, tans with 
ease 
V Dark Brown; mid-eastern skin types 
very rarely burns, tans very 
easily 
VI Black 
Never burns, tans very 
easily 
  
 
 
 
2.1.3 ETIOPATHOGENESIS OF VITILIGO 
Vitiligo is a multifactorial polygenic disorder with complex 
pathogenesis. Although several theories have explained the loss of epidermal 
melanocytes in vitiligo, the precise cause remains unknown2.  
The theories include autoimmune, cytotoxic, biochemical, oxidant – 
antioxidant and  neural mechanisms  for  destruction  of  melanocytes21.  
Various precipitating / aggravating factors also play a role in etio- 
pathogenesis of vitiligo like trauma – physical or emotional 3.  
Autoimmune theory :  
This theory is based on the association of vitiligo with a number of 
autoimmune disorders. Organ - specific autoantibodies to thyroid, gastric 
parietal cells and adrenal tissue are found in the serum of individuals with 
vitiligo than in general  population22,23. A complement  fixing  antibody  to  
melanocytes  has  been found in the serum of several patients, who in addition 
to vitiligo had alopecia areata, mucocutaneous candidiasis and multiple 
endocrine insufficiencies22.  
Antibodies to human melanocytes have been detected using a specific 
immunoprecipitation assay24,25 and  they have a cytolytic effect26. T-cell 
profiles are abnormal in vitiligo with a decrease in T-helper cells27-29. 
 
  
 
 
 
Neurogenic theory : 
This theory suggests that a compound is released at peripheral nerve 
endings in the skin that may inhibit melanogenesis.  
Recent studies on neuropeptide and neuronal markers in vitiligo suggest 
that neuropeptide Y may have a role30. Additionally, depigmented areas 
showed some abnormal autonomic function such as increased adrenergic tone 
and increased concentration of catecholamines31.  
Segmental vitiligo which occurs frequently in a dermatomal pattern, 
supports this hypothesis. Ito and others observed the close interaction between 
melanin synthesis and the autonomic nervous system. This also includes the 
occurrence of vitiligo in neurologically compromised skin, following viral 
encephalitis, following peripheral nerve injury, among emotionally  
hyperstressed  and  psychiatric patients31,32. 
Self-destruct theory of Lerner : 
 This suggests that melanocytes destroy themselves due to a defect in 
natural protective mechanism, which removes some of the pre-melanogenesis 
metabolites. This hypothesis is based on experimental studies of cutaneous 
depigmentation by chemical compounds that have selective  lethal effect on 
functional  melanocytes33.      
 
 
  
 
 
 
Oxidative stress theory : 
Oxidative stress is reported to play a role in progress of vitiligo. During 
oxidative stress, molecular oxygen is reduced to form superoxide radicals. 
Further, superoxide radicals dismutate to hydrogen peroxide either 
spontaneously or by the action of superoxide dismutase.  
In epidermal cells, hydrogen peroxide levels increase due to oxidative 
stress from environmental trauma such as Ultra Violet radiation B (290 – 320 
nm). Moreover, there is a basal level of oxidants in cells that are the by-
products of normal endogenous metabolic processes.  
Although a system of enzymatic and non-enzymatic antioxidants 
provide protection against Reactive Oxygen Species (ROS), an imbalance 
between oxidants and antioxidants   can lead to  disruption  of  cellular  
functions34. 
Antioxidant deficiency theory :  
According to this hypothesis, there is a breakdown in the antioxidant 
defence of the epidermis leading to melanocyte toxicity. An abnormally high 
catecholamine discharge in the epidermis and dermis could lead to skin 
ischaemia and subsequent overproduction of Reactive Oxygen Species 
(ROS).This theory is supported by the observation of low levels of catalase 
activity in the epidermis of vitiligo subjects. This oxidative stress could lead to 
  
 
 
 
the accumulation in the skin of high concentrations of 6- and 7- biopterins, 
which inhibit tyrosinase activity and are extremely cytotoxic to melanocytes20. 
 The antioxidant imbalance has also been confirmed in peripheral blood 
mononuclear cells of vitiligo subjects. It was correlated to raise intracellular 
production of ROS and impairment of mitochondria35. These findings support 
the concept of a possible systemic oxidative stress in vitiligo.              
Melanocyte Growth Factor reduction hypothesis : 
The normal population density of melanocytes in the skin is possibly 
regulated by a growth factor originating from keratinocytes, fibroblasts and 
various other tissues. 
 It has been proposed that depigmentation in vitiligo might be due to 
reduced local and circulating levels of growth factor, which is necessary for the 
normal proliferation and maintenance of melanocytes20. 
Genetic factors : 
Some vitiligo individuals give a family history of vitiligo, which 
probably indicates the role of genetic factors in the pathogenesis. Earlier, 
vitiligo was thought to be seldom inherited. At present, the consensus is that 
the familial incidence is between 20% and 30%.Inheritance was thought to be 
autosomal dominant with variable expression and incomplete penetrance. 
 
  
 
 
 
The possibility of an autosomal recessive or its polygenic inheritance 
with somatic expression decided by precipitating factors has also been 
suggested. Recent observations suggest a polygenic multifactorial inheritance 
and a role of acquired factors for its chemical expression. 
No Human Leukocyte Antigen (HLA) is established for vitiligo, 
although associations with HLA-DR4 in black coloured people, HLA-B13 in 
Moroccan Jews and HLA-BW35 in Yemenite Jews with vitiligo have been 
reported (20). Vitiligo has been reported in monozygotic twins also36. 
Melanocytorrhagy in vitiligo: 
Dendrites of melanocytes help in transfer of melanosomes to the 
surrounding  keratinocytes  and  also  help  in  their  adherence  to basal  
membrane. Cultured vitiligo melanocytes show stubby dendrites. Cultured 
normal melanocytes show loss of dendrites and sometimes melanocyte 
detachment on adding hydrogen peroxide. 
New theory of  melanocytorrhagy  proposes  that  Non-segmental 
vitiligo (NSV) is a primary melanocytorrhagic disorder with altered 
melanocyte response to friction and possibly other types of stress including 
their detachment and subsequent transepidermal loss. Loss of melanocytes is 
not balanced by influx of melanocytes from the follicular reservoir, where 
melanocyte stem cells are probably  situated 37. 
 
  
 
 
 
Convergence theory : 
Researchers have come to a conclusion that genetic influences have a 
role in causing vitiligo in addition to stress, accumulation of toxic compounds, 
infection, autoimmunity, mutation and melanocyte proliferation38. 
2.1.4   CLINICAL FEATURES 
Vitiligo can begin at any age, but in 50% of cases it develops before the 
age of 20 years. The condition is gradually progressive, sometimes extending 
rapidly over a period of several months and then remaining quiescent for many 
years. Hypomelanotic macules are usually first noted on the sun exposed areas 
of skin, on the face or on the dorsa of hands. Damage to the normal skin 
frequently results in an area of depigmentation – Koebner phenomenon. Areas 
subjected to frequent trauma are likely to be affected, for example the dorsa of 
hands, feet, elbows, knees and ankles.  
The distribution of lesions is usually symmetrical, although sometimes it 
is unilateral and may have a dermatomal arrangement. Rarely there is complete 
vitiligo, although a few pigmented areas always remain. 
   A typical lesion is a well-defined depigmented macule, which often 
shows a variable number of depigmented hairs and without any change in the 
skin texture. In many cases, the margin is hyperpigmented. Sometimes the 
depigmented area is surrounded by a comparatively hypopigmented zone and is 
  
 
 
 
seen to be separated from the normal skin by a thin hyperpigmented rim 
(trichrome vitiligo). 
Quadrichrome vitiligo shows marginal perifollicular hyper- 
pigmentation characteristic of repigmenting vitiligo20.  
Pentachrome vitiligo with five shades of colour has been described. 
Blue vitiligo is vitiligo macules occurring in the sites of post-inflammatory 
hypermelanosis39. 
In addition to premature greyness of the hair, uveitis also rarely occurs40. 
Careful examination of ocular fundus may show abnormalities41.  Also, there 
has been reports of increased incidence of deafness42. 
  2.1.5 CLASSIFICATION OF VITILIGO  
Vitiligo is classified based on the distribution, extension and number of 
hypopigmented lesions into localized and generalized types43. Depending upon 
the progression of the lesion, it can be classified into stable and unstable 
vitiligo44. 
A. I. Localized vitiligo: 
1) Focal vitiligo :  
 Usually a solitary macule or a few scattered macules in one area (focal) and                     
non-dermatomal distribution. 
  
 
 
 
2) Segmental vitiligo:  
 Unilateral macules in a dermatomal or quasi-dermatomal distribution. This 
type of  vitiligo has  an  early  onset  of  age.   It  is  not  associated  with  
thyroid  disease  or  other  autoimmune  diseases. 
3) Mucosal type: 
    Involvement of mucous membrane sites only. 
A. II. Generalized vitiligo: 
1) Acrofacial vitligo:                                                                                             
Depigmentation of the distal parts of limbs (hands and feet), face and 
periorificial areas.                                                                                                                                              
2) Vitiligo vulgaris:  
 It is the most common pattern. Depigmented patches are widely and usually                   
symmetrically distributed. 
3) Vitiligo universalis:  
 In some cases, almost the entire body surface is achromic, with only a few 
small  islets of normally coloured or hyperpigmented skin. 
 
 
  
 
 
 
B. I. Stable vitiligo: 
 No progression of existing disease or appearance of new lesions in the last six             
months. 
B. II. Unstable vitiligo 
 The appearance of new lesions  and / or increase in the size of existing lesions           
in the last six months and/or duration of disease less than six months. 
2.1.6 COURSE OF VITILIGO 
 The course of the disease is unpredictable and uncertain, most of them 
showing tendency towards slow progression. Lesions in the pseudo- segmental 
type  remains  static  for  an indefinite  period  after  a certain  degree  of  
regional  extension. 
  In vitiligo vulgaris, lesions develop on different areas in succession 
with varying rapidity. In some, extension of individual lesions and 
development of new lesions at different sites occur in episodic bouts with the 
intervening quiescent period varying from weeks to years. Many lesions remain 
static for an indefinite period or show some degree of spontaneous regression 
with the development of pigment spots. Others may show repigmentation of 
some lesions, extension of others and appearance of new lesions at other sites 
simultaneously. At times, the pigment spots that occur spontaneously or in 
response to therapy disappear, but may reappear. Complete spontaneous cure is 
  
 
 
 
extremely rare. Sometimes residual depigmentation may be left behind after 
repigmentation of a large macule20.  
2.1.7 HISTOPATHOLOGY OF VITILIGO 
Routine histopathology shows the absence of melanin granules in 
vitiliginous areas. Histochemical studies show a gross lack of dopa-positive 
melanocytes in the basal layer along with unusually large, highly dendritic, 
melanized melanocytes in the epidermis and numerous melanophages in the 
dermis of the border area. A dermal lymphocytic infiltrate has been reported at 
the active margins of a vitiligo macule along with extracellular granular 
deposits. The dopa reaction is not positive in amelanotic skin. Signs of 
degeneration of melanocytes and prominence of dendritic Langerhans cells  
and  indeterminate  cells  have  been  demonstrated  in  electron  microscopic  
studies. 
Inactive melanocytes were found to have converted into active   
melanocytes in repigmenting areas. Decreased dendricity and increased 
intracellular space between melanocytes and keratinocytes have been reported 
in vitiliginous patches20. 
 2.1.8 VITILIGO THERAPY 
Modern treatments can be divided into the following categories: 
 
  
 
 
 
I. General aspects 
II. Medical treatment 
III. Surgical treatment 
IV. Cosmetic camouflaging 
V. Bleaching 
I. General aspects: 
 Patients should be told about the need for a good general health and a 
balanced nutritious diet rich in proteins, vitamin B-complex, vitamin E and 
minerals such as copper, zinc and iron.  
           They need to be instructed regarding avoidance of physical, chemical 
and emotional trauma as far as possible. Avoidance of soaps and detergents 
containing phenolic compounds, rubber goods and contact exposure to other 
chemical agents known to be detrimental to melanisation is advisable. 
II. Medical treatment: 
1. Psoralen compounds and Ultraviolet A (PUVA) therapy: 
Topically, treatment using a combination of psoralen derivative or other 
photosensitizing agent, followed by irradiation with long wave ultraviolet light 
constitutes photochemotherapy. When it uses the psoralen group of drugs with 
  
 
 
 
long wave UV irradiation, then it is called PUVA therapy. It is called 
PUVASOL therapy when sun exposure is utilized as the source of UVA. 
2. UVB phototherapy: 
Broadband UVB lamp increases the chance of phototoxicity and skin 
cancer. Narrow band UVB therapy obviates this and more effective than PUVA 
therapy. Other advantages are: a) since no oral medication is required, no side 
effects of psoralens are seen; b) can be used in pregnancy and childhood; c) no 
post-exposure eye protection is necessary and d) exposure time is shorter than 
with PUVA. 
3. Excimer LASER: 
The 308 nm xenon chloride excimer laser is an effective and safe 
modality for the treatment of chronic stable vitiligo. Good results are achieved 
in a short duration of time.  
 Treatment is given twice or thrice weekly for 10 – 15 sittings. Initial 
pigmentation is observed by 4-8 weeks. It acts through immunomodulation by 
affecting the T cells. Repigmentation is fastest with thrice weekly treatment. 
4. Topical corticosteroids:  
Topical corticosteroids have become the first line of treatment in 
patients with a few localized lesions.  
  
 
 
 
 Potent fluorinated corticosteroids yield results when used for a period 
of 2 to 4 months but side effects (atrophy, telangiectasia, striae) may develop, 
in which case, treatment needs to be interrupted. Percutaneous absorption may 
result in chronic adrenal insufficiency. 
5. Oral corticosteroid therapy: 
Systemic corticosteroid therapy has been advocated in the pulse form in 
order to reduce the side effects. Oral minipulse (OMP) therapy has been 
considered as a safe one. 
III. Surgical treatment: 
 In selected cases of vitiligo or other types of leukoderma, there is a 
scope for surgical treatment. They are surgical excision, dermabrasion, 
micropigmentation, punch grafting, minigrafting, thin Thiersch grafting, 
epidermal grafting and transplantation of invitro cultured epidermis bearing 
melanocytes. 
IV. Cosmetic camouflaging: 
Suitable cosmetic preparation may help many patients by masking the 
achromic macules. Many proprietary cosmetics are available worldwide for 
different skin complexions. 
 
 
  
 
 
 
V. Bleaching (or) depigmentation: 
In extensive vitiligo with scattered pigmented islands of skin and 
without any hope of recovery, removal of remaining pigment to give the skin a 
uniformly white appearance may be cosmetically desirable. Depigmentation 
may be achieved  with  the use  of  a  20%  cream  of  monobenzyl  ether of  
hydroquinone  for  3 – 6 months  or  longer. 
 2.2.1   HISTORY OF CLINICAL NEUROPHYSIOLOGY 
The  developments  in  clinical  neurophysiology  are  closely  linked  to  
the  discovery  of  electricity.  Lugi  Galvani  was  the  professor  of  Anatomy  
at  the  University  of  Bologna.  Galvani (1791 )  discovered  that  the  nerves  
were  the  good  conductor  of  electricity.  His  observations  revealed  the  
relationship  between  electrical  stimulation  of  the  nerves  and  muscle  
contraction.  Galvani  believed  that  electricity  was  generated  by  the  body  
and  channelled  through the  nerves. 
           Carlo  Matteucci,  Professor  of  Physics  in  Pisa,  Italy,  investigated  
the  localisation  of  electricity  in the  muscle  nerve  preparation  and  
proposed  the  concept  of  electrophysiology  based  functioning  of  the  
nervous  system. 
           Duchenne,  in  1833  was  the  first  to  systematically  study  the  
neuromuscular  disease. He developed the equipments and techniques for 
electrical stimulation. 
  
 
 
 
In 1850, Helmholtz succeeded  in  measuring  the  conduction  velocity  
of  nerve  in  frog  by  mechanically  recording  the  muscle  twitch.   
           In  1851,  Du  Bois  Raymond  recorded  the  action  potential  of  
voluntarily  contracting  muscle  using  jars  of  liquid  as  electrode. This was 
the beginning of eletctromyography. 
           The  method  of  electro  diagnosis,  based  on  faradic  and  galvanic  
current  was  introduced  by  Erb  in  1861.  Erb  was  the  first  to  demonstrate  
increased  electrical  irritability  of  motor  nerves  in  tetany,  which  is  known  
as  Erb’s  phenomenon 4. 
           Within  25  years  of  publication  of  Raymond’s  book,  Richard  Caton  
who  was  a  lecturer  at  Liverpool,  UK,  conceived  the  idea  that  the  nerve  
impulse  flows  in  and  out  of  brain  and  its  passage  might  be  detectable.  
Caton  has  already  published  his  results  in  1875,  on  peripheral  nerves and  
muscle  currents  and  was  in  search   of  their  cerebral  counter  parts.  He  
noted  that  when  both  the  electrodes  were  placed  on  the  cortical  surface,  
there  is  continuous  waxing  and  waning  of  potentials  which  was  unrelated  
to  respiratory  and  cardiac  rhythm.  He  also  proved  their  biological  nature  
by  demonstrating  the  effect  of  anoxia  and  anaesthesia.  These  potentials  
were  abolished  by  the  death  of  the  animal.  As  a  result  of  these  
experiments,  Caton  had  not  only  discovered  electroencephalogram  but  
also  the  cerebral  potential  changes  evoked  by  sensory  stimulation. 
  
 
 
 
           Adolf  Beck  at  Department  of  Physiology,  University  of  
Jagiellonski,  Poland,  unaware  of  Caton’s  work  15  years  earlier,  was  also  
investigating   the  electrical  signals  of  brain  in  response  to  sensory  
stimuli.  It  was  Neminsky,  who  gave  the  first  photograph  of  evoked  
potential  recorded  from  cortex  of  a  cat  following  stimulation  of  sciatic  
nerve. Evoked potentials have emerged as an important electro diagnostic 
technique. 
           Richard  Caton  is  credited  for  the  first  description  regarding  
spontaneous  and  evoked  potentials  in  experimental  animals.   
           PA  Davis  had  recorded  auditory  evoked  potentials  in  1939,  but  it  
was  George  Dawson,  whose  contributions  such  as  photographic  
superimposition  and  averaging  have  helped  the  recognition  of  very  small  
but  time  locked  evoked  responses.   
           The  first  human  auditory  brainstem  evoked  potential  was  fully  
described  by  Jewett  and  Williston  in  1971.  Sohmer  and   Feinmesser  
(1967) had  recorded  these  waves earlier  and  attributed  their  origin  to  
brainstem  structures. 
 
 
 
  
 
 
 
 
2.2.2  AN  INTRODUCTION  TO  ELECTRO  DIAGNOSTIC  SIGNALS 
The clinical electro diagnosis involves the recording, display, 
measurement and interpretation of action potentials arising from central 
nervous system.e.g.Evoked potentials 4.  The study is carried out using the 
commercially available equipments, which have a simple and user-friendly 
programme. 
The major components of equipment are shown in Fig.1
 
 
  
 
 
 
  Biophysics: 
Normal nerve cell membrane has a resting trans-membrane potential, 
because there is an uniform distribution of positively charged ions outside and 
negatively charged ions inside the cell membrane.  
The potential difference between two points, either inside or outside the 
nerve cell membrane is zero in spite of a potential difference (voltage) across 
the nerve cell membrane. During depolarisation, voltage difference between 
two  points  occurs  and  is  responsible  for  current  flow  along  the  cell  
membrane. 
           The action potential current is due to movement of sodium and 
potassium ions. The current is resisted by intervening tissue and this resistance 
is known as impedance. 
           Voltage = current x impedance 
           Voltage is not an absolute value, but represents the difference of voltage 
between two points, which can be positive or negative. In clinical 
neurophysiology, the action potential amplitude is expressed in milli volts 
(mV) or micro volts; current in milli-amperes (mA) and impedance in mega-
ohms. Time measurements are in milliseconds (ms) or microseconds. The 
action potentials originating in nerves are displayed and interpreted as wave 
forms, in which amplitude varies with time. 
  
 
 
 
          To prevent distortion of signals, the recording system including the 
electrodes must respond to all the frequency components within the potential of 
interest and exclude the unwanted frequencies. 
Electrodes: 
          In electro diagnostic tests, three electrodes namely active, reference and 
ground are used. The action potential is measured between active and reference 
electrodes and the ground electrode serves as zero voltage reference point.  
          The electrodes are made up of variety of metals and alloys such as 
stainless steel, platinum, silver chloride, nickel, chromium, silver and gold. An 
electrochemical reaction occurs, when a metal electrode interacts with an 
electrolyte such as sweat, electrode paste or fluid.  
This results in an electrode polarisation potential of 100 – 600 mV.  
Silver – silver chloride electrode has the advantage of stable electrode 
polarisation potentials, which results in noise – free recording. 
           Both surface and needle electrodes are commonly used in electro 
diagnostic studies. The surface electrodes are in the form of disc, cup or ring. 
Gold -plated copper disc electrodes are used. The disc electrodes are used in 
the present study as they give better stability; most importantly they prevent the 
spread of infections. The surface electrodes are placed with the help of 
electrode paste which also provides an inter phase between the patient and 
equipment. The skin is cleaned and prepared by gently abrading with cleansing 
  
 
 
 
jelly. The electrode paste is gently rubbed on the skin and then applied for 
optimal contact. The action potentials are recorded between active and 
reference electrodes. 
Filter:                                                                                                                                                      
           Filter is a device, which selectively resists the frequency domain of a 
signal. The filter band pass is the frequency range of a signal, which is 
transmitted through the filter. The frequency range in which a signal is rejected 
is known as stop band.  Between  the  pass  band  and  stop  band  is  the  
transition  band,  which  is  characteristic  of  the filter. 
           Filtering of neuro physiological signals is required for eliminating the 
noise, optimizing the recording. The noise frequencies can be eliminated, if 
these are different from the frequency components of action potential. Filtering 
is also useful in bringing out the characteristics of waveforms, which may 
otherwise be not obvious.  
           The low frequency filters remove the slowly changing low frequency 
components and allow higher frequencies to pass through. Therefore, the low 
frequency filter is also known as high pass filter. Similarly high frequency 
filers eliminate the rapidly changing high frequency components and allow the 
low frequency to pass through. Hence the high frequency filters are called low 
pass filters. 
  
 
 
 
The other method of filtering is digital filtering using mathematical 
algorithms applied to the signal after conversion into a digital form. The filters 
do lead to an alteration of waveforms because of their frequency attenuation 
and phase shift characteristics. Most signals of clinical interest contain 
significant frequency components near 50 – 60 Hz, but the use of notch filters 
to exclude noise (50 – 60 Hz) is not recommended because of distortion of the 
action potential. 
           The recommended filter settings and low cut and high cut filters in 
auditory brainstem evoked potential are low cut 10 – 100 Hz and high cut 3 
kHz 45.  
Amplifier: 
           Since the biological signals are very small, a variable degree of 
amplification (up to 500,000 times) is needed before being displayed. The 
electrode impedance includes intrinsic impedance of the electrode and the 
impedance of electrode–skin interface. For recording action potential, the 
action potential generated in central nervous system or nerve must flow 
through the electrode into the amplifier and return to the subject through the 
ground lead. Electrode impedance results in drop of the amplitude of action 
potential. This attenuated action potential reaches the amplifiers.  
           To reduce this attenuation, the impedance of the amplifiers must be 
much greater than the electrode impedance. To limit the drop in signal 
  
 
 
 
amplitude by 1%, the amplifier impedance should be 100 times the electrode 
impedance. 
           The needle electrodes have higher impedance than surface electrodes.      
The electrode and amplifier impedance both are inversely related to the 
frequency. A 100:1 ratio of electrode to amplifier impedance should be 
maintained across the range of frequencies contained in the waveform under 
study. This minimises the waveform distortion and improves noise rejection. 
Unequal electrode impedance imbalances the electrode amplifier input, 
converting some of the noise into different signal, which is amplified to the 
same extent as the neuro physiological signal. To reduce the impedance-
induced noise, the active, reference and ground electrode impedance should be 
minimized and balanced. 
Averager: 
           Averaging is a mechanism to extract very small signals, which are 
buried in larger noise, as evoked potentials are buried in EEG. By averaging, 
the signals which are time-locked become prominent and the noise which is 
randomly occurring is cancelled out. The time locked sequential responses are 
digitized and stored in the memory of the equipment. The sequential responses 
are mathematically summated, averaged and displayed. The signal-to-noise 
ratio (SNR) depends upon the number of responses averaged. 
 
  
 
 
 
                                 SNR = Signal amplitude x Number of sweeps 
                                                            Noise amplitude 
Using a sweep rejection criterion, the time locked noise signals can be 
rejected. The sweep is rejected if the incoming signal exceeds predetermined 
amplitude, which is expressed as a percentage of the input range of the 
amplifier. Typically, sweep is rejected when the signal exceeds  95% of the 
input range. It is important to appreciate the relationship between SNR and the 
number of sweeps averaged. The  number  of  sweeps  have  to  increase  four  
times  to  double  the SNR. 
Display: 
For digital display, an analog-to-digital converter (ADC) and digital 
processing techniques are required. This facility is available in all modern 
electro diagnostic equipments. The continuously varying neurophysiological 
signal is sampled at discrete time intervals and the amplitude of the signal is 
converted  into a number, following amplification and filtering. This process is 
known as analog to digital conversion. The unit of an ADC is a bit, which is a 
binary digit. The resolution capacity of an ADC is related to the number of bits. 
Resolution of ADC = 2 n (n = number of bits) 
           An ADC with 6 bits will resolve 64 levels, with 12 bits will resolve 
4096 levels and hence,  the  later will have better resolution. The polyrite 
  
 
 
 
Medicaid Neuro Perfect  Plus has 14 bits, that  has  still higher resolutions of 
16484 levels. 
       In digitalised display, certain details of the waveform may be lost because 
of the limited number of pixels used for display.  
The advantage of this technique is that the signals can be redisplayed 
with greater sensitivity without loss of waveform accuracy. The series of digital 
numeric values derived from ADC, must accurately reflect the amplitude, 
morphology and variability in the original waveform. This depends on 
sampling rate of ADC, which should be fast enough to capture the rapidly 
changing features of the waveform. The minimum sampling rate should exceed 
twice the value of high frequency components of the waveform. This criterion 
is Nyquist criterion, which sets the lower limit of analog to digital conversion 
rate. Insufficient sampling rate results in distortion of waveform (Aliasing 
effect). The sampling done as per Nyquist criterion, may still not ensure full 
representation of waveform, therefore more rapid sampling rate (5 – 10 times 
the highest frequency of the signal) is required. 
Sweep time: 
On high gain or sensitivity, the latency measurements are shorter, 
because it becomes possible to visualize smaller take offs from baseline. The 
changes in peak latency are less affected by sensitivity, because of easy 
identification of the peak compared to the onset of action potential. Similarly, 
duration of action potential increases as the display sensitivity is increased. 
  
 
 
 
Increase in sweep speed results in shortening of latency, although this effect is 
variable and is of small magnitude. In digital display, the horizontal display 
resolution is limited by the number of horizontal pixels in each given division. 
It is possible to have automatic cursor placements for the measurement of 
latency, duration and amplitudes. Such measurements should be visually 
monitored so that noise and other artefacts are not included in the 
measurement. 
Stimulator: 
The stimulators are required for evoked potential studies. For reducing 
the imbalance of impedance between active and reference electrodes, 
electrically isolated stimulators, matched recording electrodes with good skin 
preparation, pacing the ground electrode between stimulating and recording 
electrodes, avoiding a bridge between electrodes by electrode jelly or sweat and 
use of short cables for stimulating and recording are helpful.  
Evoked potential: 
Electrical potentials that occur in the group of neurons in response to the 
stimulation of a sense organ,  which can be recorded by surface electrodes are 
known as Evoked Potential. 
Brainstem Auditory Evoked Potential: 
           Brainstem  auditory  evoked  potentials  typically  use  a  click  stimulus 
that  generates  a  sequential  activation  of  brainstem  auditory  pathway   i.e.,  
  
 
 
 
response  from the hair  cells  of  cochlea,  the  signal  travels  along  the  
auditory  pathway  from  the  cochlear  nuclear  complex  to the  inferior 
colliculus  in  midbrain  generating  wave I   to  wave V.  They occur 10 msec  
after  auditory  stimuli. 
Brainstem Auditory Evoked Potentials / Auditory Brainstem Response 
(ABR) / Brainstem Evoked Response Audiometry  /  Far-Field  
Electrocochleography:      
           The  term  brainstem   auditory   evoked   potentials   are   not   
completely    accurate   because  the   roster   of   generators   includes   distal  (  
with  respect  to  the   brainstem )   cochlear   nerve   and   also  the    
thalamocortical   auditory   radiations,   neither   of   which   is   within   the   
brainstem.  Other   synonyms     include   auditory   evoked   brainstem   
response, far-field   electro-cochleography and brainstem evoked response   
audiometry45.  The   procedure   of   evoked   response   audiometry   is   same   
as   that   of   ABR.  In   audiometry,   the   evoked  response   is   obtained   
with   different   intensities   of   click   stimuli.  Physiologic   testing  of   the   
function   of   the   eighth   cranial   nerve   and   its   connections   provide   
sensitive,  quantitative    measures   of   mild   or   early   damage   to   the   
peripheral   or   central   components   of   the   nervous   system46. 
 
 
  
 
 
 
2.2.3  Role  of  electrophysiological  studies  in  vitiligo 
Nikifordis  et  al.  1993,  studied  the  auditory  brainstem  response  in  
30  patients  with  vitiligo  to  detect  the  subclinical  auditory  abnormalities.  
Their  findings  revealed  a  statistically  significant  ( p < 0.01 )  
reduction  in  first  peak   latency  and  a  statistically   significant  ( p < 0.01 )  
increase  in     I – III  inter  peak  latency  in  the  patients  when  compared  
with  that  of  controls 10. 
The  decrease  in  first  latency  may  be  due  to  the  decrease  in  
number  of  active  melanocytes  in  the  inner  ear  and  the  resulting  
impairment  of  ionic  exchange  between  perilymph  and  endolymph.  The  
prolonged  I – III  inter  peak  latency  may  be  due  abnormal  synaptic  
activity  and  transmission  of  action  potential  from  the  auditory  nerve  to  
the  superior  olive. 
Bassiouny  et  al.  1998,  performed  BERA  in   vitiligo  subjects.  He  
found  a  statistically  significant  decrease  in  latency   of  wave  I,  which  
may  be  due  to  mild  cochlear  lesion   in  the  melanin  lacking  individuals.  
The  observed  increase  in  I -  III  inter  peak   latency  was  due  to  decrease  
in  wave  I  latency,  as  the  absolute  latency  of   wave  III   in  their  study  
was  within  normal  limits 48.    
Ozuer  et.  al  1998,  performed  BERA  in  50  individuals  with   
vitiligo  and   compared   the  results   with   that  of   50   heathy  controls.  
  
 
 
 
With  regard  to  latencies  and amplitudes,  there  was  no  statistically  
significant  difference  between  both  the groups.  They  suggested  post-
mortem   histopathological   study  of  the  inner  ear  and  brainstem  in   
vitiligo  subjects  to  understand  the  pathology 12. 
Aydogan  et  al.  2005,  studies  brainstem  auditory  evoked  response  
of  57  vitiligo  patients  and  healthy  controls.  The  I,  III   and  V  latencies  
and  inter  peak  latencies  of  I – III,  III – V  and  I – V  were  compared  
between  the  groups.  
A  statistically  significant  increase  in  the  latency  of wave  III  and  
inter peak   latency  I – III  in both  the  ears  and  a  significant  increase  in  
the  latency   of  wave  V  in  the  right  ear were  noted.   
           The  prolonged  third  and fifth  peak  latency  and  I – III  inter  peak  
latency  were  related  to  their  superior  olivary  nucleus ( SON )  and  upper  
brainstem  or  inferior  colliculus  pathology.   
This  may  be  due  to synaptic  activity  abnormality  and  abnormal  
transmission  of  action  potential  from  the  auditory  nerve  to  the  cochlear  
nucleus  and  from  the  cochlear  nucleus  to  the  SON  and  inferior  
colliculus.  Hence, vitiligo  may  be  associated  with  delay  in  
synchronization  of  action  potentials  in  these  nuclei 49. 
Shalaby  et  al.  2006,  studied  the  auditory  function  affected  in  
vitiligo  patients  with  different  distribution  and  duration.  They  explained  
  
 
 
 
that  the  disorders  of   hypopigmentation  for  a  long  duration  may  cause  
the  degeneration  of  outer  hair  cells  degeneration  both  structurally  and  
functionally  beginning  from  the  basal  turn  of    cochlea  with  intact  inner  
hair  cells.  Another  explanation  was  about  endolymph  calcium  levels. The  
calcium  levels  in  endolymph  increased  from  the  base  to  the  apex  and  
endocochlear  potentials  decreased  towards  apex.  There  was  no  significant  
calcium  gradient  noted  in  albinos  and  there  was  less  endocochlear  
potential  decline.  These  results  confirm  the  involvement  of  melanin  in  
the  calcium  active  transport   into  the  endolymph.  In  their  study,  there  
was  no  statistically  significant  difference ( p > 0.05 )  between  cases  and  
controls. They  concluded  that   some  of  the  vitiligo  patients may have 
auditory defect depending on individual’s susceptibility, residual  melanocyte  
number  in  the inner ear  and nature  of immunological abnormalities50. 
2.3.1  SUPEROXIDE  DISMUTASES  IN  OXIDATIVE  STRESS 
           Superoxide  dismutases (SODs)  are  metalloenzymes  that  catalyze  the  
dismutation  of  the  superoxide  anion  to  molecular  oxygen  and  hydrogen  
peroxide  and  form  a  crucial  part  of  the  cellular  antioxidant  mechanism 66. 
                        
SODs  are  classified  into  three  types  according  to  their  metal  content : 
copper / zinc (Cu / Zn),  iron (Fe)  and   manganese (Mn).  SOD  is   distributed  
  
 
 
 
widely  in  both  plants  and  animals.  It  is  present  in  higher  concentrations  
in  liver,  heart,  kidney  and  erythrocytes.  There  are  three  forms  of  SODs  
in  human  beings.  They  are  mitochondrial   MnSOD,  cytosolic  Cu/Zn-SOD  
and  extracellular  SOD67.  Extracellular  SOD  is  found  in  the  interstitial  
spaces  of  tissues  and  in  the  extracellular  fluids,  which  accounts  for  the  
majority  of  the  SOD  activity  in  the  lymph,  synovial  fluid  and  plasma 
68,69. 
           The  amount  of  SOD  in  cellular  and  extracellular  environments  is  
important  for  the  prevention  of  diseases  linked  to  oxidative  stress.  The  
reaction  catalysed  by  SOD  is  very  fast,  having  a  turnover  of  2 x 109 M-
1sec-1  and  the  sufficient  amount  of  enzymes  present  in  the  cells  and  
tissues,  keep  the  superoxide  concentration(O2-)  very  low 66. 
           Catalase is a hemoprotein.  It  contains four   heme  groups.  Catalase   is  
found  in  blood, bone  marrow,  mucous membranes,  kidney  and  liver.  
Inside   the  cell,  it  is found  in  peroxisomes.  It  catalyses  the  conversion  of  
hydrogen  peroxide  into  water  and  molecular  oxygen  (Harper, 2000).  
                                  
2.3.2   Oxidative  stress  in  vitiligo 
There  are  several  studies  on  the  oxidative  stress  in  vitiligo.  
Oxidative  stress  may  be  due  to  excess  production  or  inadequate   removal   
  
 
 
 
of   reactive  oxygen  species (ROS)  or  free  radicals.  A  radical  is  a  
molecule  having  an  unpaired  electron 15,51.  Superoxide,  nitric  oxide,  
hydroxyl,  alkoxyl  and alkyl - peroxyl  (lipid)  are  radicals.  Reaction  of  a  
radical  with  a  non  radical,  forms  new  radicals,  which  in  turn  react  with  
further  macromolecules 15.   
           In a healthy  body,  the  oxidant  molecules  are  removed  by  
antioxidant  systems.  Cellular  antioxidant  defences  are  dismutase,  
peroxidise  and  catalase   enzymes15. Superoxide  dismutase (SOD)  which  is  
present  in  cytoplasm  and  mitochondria  catalyses  the  dismutation  of  
superoxide  to  hydrogen  peroxide  and  oxygen15,51.  Beta  carotene,  ascorbic  
acid,  tocopherol,  uric  acid,  coenzyme  Q  and  ferritin  are  major  
antioxidants.  Beta  carotene,  coenzyme  Q  and  vitamin  E  are  low  
molecular  weight  antioxidants  and  they  are  present  in  the  cell  membrane.  
Their  deficiency  causes  accumulation  of  ROS  leading  to  lipid  
peroxidation,  DNA  mutation,  activation  or  inactivation  of  enzymes  and 
oxidation  of  protein 52. 
           The  inherent  capacity  of  cells  to  withstand  the  oxidative  stress  is  
due  to  several  factors:  Their  ability  to  repair  oxidatively  modified  
biomolecules,  their  antioxidant  ability  and  their  capacity  to  sustain  
metabolic  requirements  by  deriving  energy  from  alternate  pathways. 
              Recently, several studies on superoxide dismutase (SOD), catalase 
(CAT),  glutathione  peroxidase (GPx)  and  nitric  oxide (NO)  have  been  
  
 
 
 
done  and different  results  were  reported  about  these  biomarker  levels.  
Some  researchers  observed  high  levels of  oxidants  and  antioxidants.  Some   
others  reported  no  difference  between  patients  and  controls.  Some   
studies  have  reported  even  low  levels  of  these  markers. 
           Yildirim  et al. 2004, Damma  et al. 2009  and Sravani  et  al. 2009 
found  high  levels  of  superoxide  dismutase  and  glutathione  peroxidase  
levels  and  low  levels  of  catalase 53,54,55  in  the  vitiligo  patients  when  
compared  with  that  of  controls. 
           Koca  et  al.  2004,  and  Akrem  et  al.  2009,  found  low  levels  of  
superoxide  dismutase,  catalase  and  glutathione  peroxidise  in  the  vitiligo  
patients  when  compared  with  that  of controls 56,57. 
           Picardo  et  al.  1994,  and  Passi  et  al.  1998,  found  no  difference  in  
blood levels  of  superoxide  dismutase,  glutathione  peroxidise,  
lipoperoxidase,  vitamin  E  and  ubiquinone  between  vitiligo  subjects  and  
controls 58,59. 
Eventhough  these  studies  had  different  results,  all  of  them  suggest  
an  imbalance  between  anti-oxidant  and  oxidant  systems in  vitiligo.  At  this  
point, further  studies  on  a  larger  population  are  necessary  to  prove  the 
role  of  these  markers  in  the  etiopathogenesis.       
 
 
  
 
 
 
                                      3.    AIM AND OBJECTIVES 
 Aim of the study was   
1. To evaluate the conduction in the auditory pathway in vitiligo subjects. 
2. To study the role of oxidative stress in vitiligo subjects. 
Objectives of the study were                                                    
1. To evaluate the audiological abnormalities using Brainstem Evoked   
     Response   Audiometry as a tool in individuals with vitiligo. 
2.  To study the role of oxidative stress by assay of serum superoxide dismutase  
     enzyme level in individuals with vitiligo. 
3.  To do a comparative study in a healthy control group. 
 
 
 
                                           
                                         
 
 
  
 
 
 
4.  MATERIALS  AND  METHODS 
The  study  was  conducted  in  the  DEPARTMENT  OF  
PHYSIOLOGY,  STANLEY  MEDICAL  COLLEGE,  CHENNAI – 1,  from  
2014  to  2015  after  getting  approval  from  the  Institutional  Ethical  
Committee,  Stanley  Medical  College,  Chennai – 1. 
4.1  SELECTION  OF  SUBJECTS 
4.1.1  Study  group:  
          40 individuals affected by vitiligo of various dermatomes and 
distribution were recruited from the Department of Dermatology and 
Department of Cosmetology, Stanley  Medical  College ,  Chennai-1. 
Inclusion  criteria: 
          1. Clinically  diagnosed  vitiligo  patients. 
          2. 15 -  40  years  of  age  group. 
          3. Both  gender. 
Exclusion  criteria: 
1. Age  less  than 15 years  and  more  than 40  years.            
          2. Subjects  with  any  other  chronic  dermatological  diseases  including 
depigmentation  disorders. 
  
 
 
 
         3. Subjects  who  were  exposed  to  risk  factors  known  to  be  
responsible  for  sensory  neural  hearing  loss  eg.  ototoxic  drug  intake,  
chronic  noise  exposure,  head  trauma  etc.  
4.  External  or  middle  ear  diseases. 
          5.  H/O  ear  surgery. 
          6. Any history  suggestive of  anaemia,  diabetes mellitus,  hypertension,  
thyroid disease  and  other  autoimmune diseases. 
 4.1.2  Control  group: 
         40  age  and  gender  matched  healthy  controls  were  selected from  the 
volunteers  among  the  hospital  staffs  and  accompanies  of  patients. 
Study  Design:  Case  control  study 
Place  of  study:   
Neurophysiology  Laboratory  of  Research  Wing,  Department  of  
Physiology,  Stanley  Medical  College,  Chennai – 1. 
 
 
 
 
  
 
 
 
 4.2  METHODOLOGY 
4.2.1  BRAINSTEM  EVOKED  RESPONSE  AUDIOMETRY: 
Brainstem  Auditory  Evoked  Potential  (BAEP)  recording  was  done  
by  using  the  instrument,  Neuro  Perfect  Plus  Medicaid  Polyrite  Hardware,  
Solokraft,  India. 
          After  taking  a  brief  history,  clinical  examination  was  done.   All  the  
study  subjects  were  examined  under  good  light.  Detailed   dermatological  
examination   including  size,  shape,  number,  colour  and  distribution  of  
lesions  was   done.  The  individuals  were  made  to  relax  and  be  
comfortable  prior  to  the  test. The  complete  procedure  and  objectives  of  
the  study  were  explained  in  detail  to  the  individuals  in  their  regional    
language. The  informed  and  written  consent  ( Annexure  I ) was  obtained  
from  the  individuals.  The  complete  examination  of   both  the external  ears  
was  done  and  wax  was  removed.  Then  pure  tone  audiometry  was  done  
in  the  ENT   department,  Stanley  Medical  College  Hospital,  Chennai-1. 
Both  the  vitiligo  subjects  and  controls  had  a  prestructured   
proforma  completed     ( Annexure  II ). Venous  blood  sample  was  collected   
from  both  the  vitiligo  and  control  groups  for  the  estimation  of  
superoxide  dismutase  enzyme.   
 
  
 
 
 
             Brainstem  auditory  evoked  potentials  were  recorded  in  40 healthy  
individuals  of  both  gender  with  age  ranging  from  15  to  40  years. In  
order  to  establish  the  reliability  of  the  method,  several  repetitions  of  
Brainstem  Auditory  Evoked  Potential recordings  were  performed  on  
different  days  and  at  different  hours. BAEPs  were  recorded  in 40  
individuals  of  both  gender  affected  by  vitiligo  of  various  dermatomes  
and  distribution,  in  the  age  group  ranging  from  15 – 40 years. 
4.2.1.1  PRE–REQUISITES:  
- The  subjects  were  clearly  instructed  to  have  shampoo  head  
bath. 
- The  subjects  were  instructed  to  avoid  oil  on  hair or  hair  spray. 
- The  subjects  were  instructed to avoid  beverages  and  strenuous  
exercise  on  the  day of  recording. 
- The  subjects  were  made  to  get  accustomed  to  research  
laboratory  and  be  relaxed. 
- The  research  room  was  made  comfortable  and  noise  free.   
- Uniform  normal  room  temperature  was  maintained. 
- The  subjects  were  grounded  properly. 
 
  
 
 
 
4.2.1.2  INSTRUMENT SETTINGS FOR RECORDING BAEP 
1.  Recording Electrodes: 
                  The  gold  plated  copper  disc  electrodes  for  recording  BAEPs  
were  used.  No  significant  difference  in  latency  and  amplitude  have  been  
observed when  BAEPs  were  recorded  either with  needle  or  surface  
electrodes.  Surface   electrode  recordings  were  preferred  because  they  were  
painless,  had  better   stability  and  less  chances  of  infection.  1 cm  disc  
electrodes  filled  with  conducting  paste  were  used.  The  electrode  
impedance  was  kept  below  5 kilo ohms. The  BAEP  was  recorded  from  
the  ipsilateral  ear  with  reference to  the  vertex.  The  two  channels  which 
were  recorded  from  the  ipsilateral  and  contralateral  mastoids  are  referred  
to  as  Ai  and  Ac  respectively.  Reference  electrode  is  Cz..  Ground  electrode  
is  Fz.   Vertex  is   the  suitable  location  since  waves  II – V  have  good  
amplitude  with  little  muscle  artefact. 
2.  Montage  Chosen: 
- Active  electrode – Ipsilateral  mastoid:  Ai 
- Reference  electrode – Vertex: Cz 
- Ground  electrode -  a  point  in  front  of  the  reference  electrode:  
Fz 
 
  
 
 
 
3.  Amplifier  and  Averager: 
                 BAEPs  were  recorded  using  an  amplification  of  200,000 – 
500,000.   Two  to  three  repetitions  were  done  and  superimposed  to  check  
for  reproducibility.   BAEP  repetition  was  superimposed  exactly.  A  10  ms 
epoch  after  the  click  stimulus  was  averaged,  amplified  and  displayed  on  
the  monitor. 
4.  Filter  settings:  
               The  low  filter  was  set  at  100 Hz  and  high  filter  at  3,000 Hz. 
5.  Auditory  stimulation: 
               The  BAEPs  were  produced  by  a  brief  click  stimulus,  which  is  a  
square  wave  pulse  of  0.1  ms  duration.  The  pulse  moves  the  ear  phone  
diaphragm  away  from  the  subject’s ear  which  is  a  rarefaction  phase  
stimulus.  Wave I  amplitude  is  greater  with  rarefaction  compared  to  
condensation  stimulus.  Since  recognition  of  wave  I  is  very  important,  
rarefaction  click  polarity  was  chosen.  Clicks   were  usually  presented  10 – 
70 times  per  second. 
                The  slower  or  intermediate  rates  were  preferred  because  
waveforms  are  well  defined.  A  click  rate  of  11Hz  was  used.  The  click  
stimulates  not  only  the  ipsilateral  ear,  but  also  travels  via  bone  and  air  
conduction  to  stimulate  the  contralateral  ear  at  an  intensity  of  40 – 50 dB  
  
 
 
 
lower  than the  ipsilateral  ear.  White  noise  at  30 – 40 dB  blocks  the  
stimulation  of  contralateral  ear  thus  prevents  false  BAEP  responses. 
4.2.1.3  Procedure: 
                BAEP  recording  was  done  in  Neurophysiology  Laboratory  of  
Research      Wing,  Department  of  Physiology,  Stanley  Medical  College  
using  Neuro  Perfect  Plus – Medicaid  Polyrite  Hardware,  Solokraft,  India.  
The  left  and  right  ears  were  tested  separately  in  all the subjects.  The  
laboratory  temperature  was  maintained  uniformly.  The  recordings  were  
done  in  the  forenoon  between  10  am  to  12  noon  in   sitting  posture  two  
hours  after  a  light  breakfast.  The  subject  was  asked  to  recline  on  a  chair  
comfortably  with  their  feet  placed  on  a wooden  board.  
               In  order  to  avoid  hearing  defect  interferences,  pure  tone  
audiometry  was  done  at  ENT  department,  Stanley  Medical  College  
Hospital.  The  body  temperature  was  measured,  since  hypo  or  
hyperthermia  may  cause  alterations  in  latencies  of  both  absolute  and  inter  
peak.  The  disc  electrodes  were  placed  on  scalp  by  10 – 20  standard  
system  with  conducting  jelly.  The  skin  and  electrode  impedance  were  
checked.  Since  the  potentials  recorded  are  in  far  field,  well  displaced  
from  the  site  of  impulse  generation,  the  waveforms  recorded  were  very  
weak  and  hence  amplified.  The  amplification  is  achieved  by  improving  
the  signal : noise  ratio.  To  improve  signal  to  noise   ratio,  three  parallel  
approaches  are  designed  to  achieve  the  goal. 
  
 
 
 
Filtering:   
              This  is  employed  to  reduce  the  recording  bandwidth,  so  that  
only  the  important  components  of  the  signal  are  recorded. 
Repeated  stimulation:   
              This  is  done  with synchronous  time  domain  averaging  to  increase  
the  amplitude  of  the  components  of  the  signal.  In  real  time  situations,  
these  two  can  be  achieved  by  connecting  the  recording  electrodes  to a pre  
amplifier,  with  appropriate  filter  settings. 
Polarity  alteration:                                                                                         
               By  altering  the  polarity  of  impulses  recorded,  the  artefacts  are  
cancelled  making  the  brainstem  waves to  stand  out.  The  earthing  
electrode  is  important  for  proper  functioning  of  pre  amplifier. 
               The  automatic  artefact  rejection  was  used.  The   sweep  velocity  
was       1 ms.  The  click  acoustic  stimuli  at  a  rate  of  11 pulse  per  second  
at  an  intensity  of  80 to 90 dB  hearing  level  was  given  to  the  ear  
stimulated,  was  given  through  head  phone  supplied  by  Medicaid.  The  
continuous  1000  auditory  click  responses  were  summated,  averaged  and  
displayed.  All the techniques  of  measurement,  duration and research  
laboratory  temperature  were  maintained  uniformly  throughout  the  study 45. 
 
  
 
 
 
4.2.1.4  PARAMETERS STUDIED: 
              The  Absolute  wave  latency  I, II, III, IV and V,  Inter  Peak  Latency 
I – III, I – V, III – V  and  amplitudes  of  waves  were  measured.  The  wave  
pattern  in  BAEP  recording  is  5  or  more   peaks  within  10 ms of  stimulus.  
Initial  five  peaks  have  clinical  significance.  The  succeeding  peaks  VI – 
VIII  are  quite  variable  and  are  not  clinically  useful.  In  normal  subjects,  
waveform  IV – V  forms  complex.  Absolute  amplitudes  are  too  variable  to  
be  of  any  clinical  use  even  in  inter  ear  comparison. 
Electro physiological study: 
               Brainstem  auditory  evoked  potentials  are  the  potentials  recorded  
from  the  ear  and  vertex  in  response  to  a  brief  auditory  stimulation. 
It  is  used  to  assess  the  conduction  through  the  auditory  pathway  
up  to  the  midbrain.  Brainstem  auditory  evoked  potentials  comprise  of  5  
or  more  peaks  within  10  ms  of  the  stimulus4. 
               The  auditory  nerve  and  brainstem  auditory  evoked  potentials  are  
volume  conduction  to  surface  electrodes.  At  the  vertex  and  ear  lobe,  
these  form  vertex  positive  and  vertex  negative  waves  which  are  known  
as  brainstem  auditory  evoked  potentials.  The  peak  to  peak  amplitude  of  
these  waves  recorded  from  the  scalp  is  only  about  1/100th  the  amplitude  
of  ongoing  spontaneous  EEG  activity.  There  are  5  or  more  distinct  
waveforms  recorded  within  10  ms  of  the  auditory  stimulus.  By  
  
 
 
 
convention,  BAEPs  are  recorded  positive  up,  which  is  the  opposite  of  
most  electro  physiological  recording. 
Origin of brainstem auditory evoked potentials: 
Waveform I – Vestibulo cochlear nerve 
Waveform II – Cochlear nucleus 
Waveform III – Superior olivary nucleus 
Waveform IV – Lateral lemniscus 
Waveform V – Inferior colliculi 
4.2.1.5  NORMAL BAEP 
               Classical  BAEP  consists  of  5 – 8  vertex  positive  peaks,  which  
are  labelled  using  Roman  numerals.  The  troughs,  immediately  following  
peaks  are  designated  by  the  same  numerical with a prime  mark.  The  
important  features  in  recognition  of  different  waveforms  are  as  follows: 
Wave  I:   
               Is  a  prominent  initial  up  going  peak  in  the  ipsilateral  ear-
recording  channel.  It  appers  1.4 ms  after  the  stimulus  and  is  markedly  
attenuated  or  absent  from  the  contralateral  ear-recording  channel.  Patients  
with  only  central  nervous  system  problems,   will  have  a  normal  wave I  
since  it  originates  from  VIII nerve.  Conversely, the  patients  with  
  
 
 
 
significant  peripheral  hearing  impairment  may  have  a  poorly  formed  or  
absent  wave I, but  relatively  normal  wave II  to  V. 
Wave  II:  
               Is  poorly  defined  in  some  adults.  It  appears  as  a  small  peak  
along  the  down  going  slope  of  wave I  or  in  the  up  going  slope  of  wave 
III.  Sometimes  the  fusion  of  waves II  and  III   results  in  M  shaped  II – 
III complex. 
Wave  III:   
               It  is  usually  a  prominent  peak  and  is  followed  by  a  prominent  
III  trough.  In  the  contralateral  channel,  wave  III  often  appears  smaller  
and  earlier  than  the  ipsilateral  ear  because  its  amplitude  is  similar  at  the  
vertex  and  contralateral  ear.  This  feature  may  help  in  wave  III  
recognition.  Some  normal  subjects  have  a  bifid wave  III,  which  is  
associated  with  a  normal  I-V  IPL.  In  some  adults,  wave IV  may  
normally  be  closer  to  wave  III  than  to  wave  V  and  give  an  appearance  
of  bifid  wave  III. 
Wave  IV and  V:  
               Wave  V  is  the  most  prominent  peak  appearing  5.5  ms  after  the  
stimulus.  It  starts  above  the  baseline  and  its  trough  is  maximal  below  
the  baseline.  On  ipsilateral  recording,  wave  V  fuses  with  IV,  resulting  in  
  
 
 
 
a  wave  IV-V  complex.  The  wave  IV  and  V  tend  to  be  separated  on  
contralateral  recording. 
The  wave  IV  and  V  may  have  the  following  patterns:                                                                                                                        
             -   Single  peak  which  is  completely  fused  as  a  tall  wide  pyramid,   
             whose   base  should  be  more  than  1.5 ms. 
- Two   peaks  which  are  close  but  still visibly  separated. 
- Wave  IV  may  be  on  the  up  going  slope  of  wave  V. 
- Wave  V  may  be  on  the  down  going  slope  of  wave  IV. 
Measurement  and  Normal  Values  of  BAEPs: 
The  following  parameters  are  measured  for  the  analysis  of  BAEP: 
- Absolute  latency  and  amplitude 
- Inter  Peak  Latencies ( IPLs ) 
- Amplitude  ratio  of  wave  V/ I  or  IV – V  complex / I 
- Inter  ear  inter  peak  differences 
Absolute  Latencies  and  Amplitudes: 
               Absolute latency is measured as the distance (expressed in ms) from  
the  beginning  of  the  first  wave  to  the  peak  of  that  wave.  The   difficulty  
is  encountered  when  the  waveforms   are  poorly  formed.  The  method  
recommended  for  latency  comparison  is  to  superimpose  the  major  
ascending  and  descending  limbs  of  waves  of  two  sides  against  a  strong  
  
 
 
 
source   of  light. Absolute  amplitude  is  measured  as  the  height ( expressed  
in  µv )  from  the  peak  of  the  wave  to  the  trough  of  that  wave.  Absolute  
amplitudes  are  too  variable  to  be  of  any  clinical  use  even  in  inter  ear  
comparison. 
Inter  Peak  Latency: 
               The  commonest  IPLs  employed  in  clinical  practice  are  I - V, I – 
III  and III – V. 
I – V  IPL: 
              The  latency  difference  is  a  measure  of  conduction  from  proximal  
VIII  nerve  through  pons  to  midbrain.  The  typical  upper  limit  of  normal  
I-V  IPL  is  4.5 ms.  This   IPL  is  slightly  shorter  in  young  women  and  
longer  in  older  women.  Normal  right  to  left  asymmetry  should  not  
exceed  0.5  ms.  The  I – V  IPL  can  be  prolonged  in  a  variety  of  disorders  
including  focal  damage  produced by demyelination, ischemia, tumours  or  
diffuse  diseases  such  as  degenerative  disorders,  hypoxic  brain  damage,  
etc. 
I – III  IPL:   
             The  latency  difference  between  wave  III  and  I  is  a  measure  of  
conduction  from  VIII  nerve  across  the  subarachnoid  space  into  the  core  
of  lower  pons.  The  I – III  IPL  can  be  increased  in  any  diffuse  process  
  
 
 
 
that  affects  the  generation  of  these  waves.  The  I – III  IPL  is  more  
susceptible  to  tumour,  inflammation  or  other  disorders  affecting  the  
proximal  portion  of  VIII  nerve,  ponto  medullary  junction  or  the  lower  
pons  around  superior  olive  or  trapezoid  bodies.  Infarction  can  also  
prolong  I – III  IPL  and  this  can  also  occur  in  meningitis  and  
subarachnoid  haemorrhage.  The  upper  limit  of  normal  for  I – III  IPL  is  
about  2.5 ms  and  right  to  left  symmetry  is  less  than  0.5 ms.   Excessive  
prolongation  of  I – III  IPL   should  be  associated  with  corresponding  
prolongation  of  I – V  IPL. 
III – V IPL:    
             It  is  a  measure  of  conduction  from  lower  pons  to  midbrain.  It  is  
influenced  by  contralateral  conduction,  although  contribution  from  
ipsilateral  brainstem  auditory  pathway  is  also  suggested.  Its   upper  limit  
is  up to  0.5  ms.  Isolated  prolongation  of  III – V  IPL  is  not  considered  
abnormal,  unless  associated  with  prolonged  I – V  or  abnormal  V/I  
amplitude  ratio.   
V/I  amplitude  ratio:  
            The  V/I  amplitude  ratio  may  be  influenced  by  filter  setting  and  
click  intensity.  Therefore,  comparison  with  the  normal  values  of  the  
respective  laboratory  is  essential 46. 
 
  
 
 
 
4.2.1.6  ABNORMAL  BAEP  
BAEP  abnormalities  will  include  one  or  more  of  the  following. 
-  Absence  of  waveforms 
- Abnormal  absolute  or  inter  peak  latencies 
- Amplitude  ratio  abnormality 
- Right  to  left  asymmetry 
Waves  I – V:    
                 Seen  in  most  normal  subjects,  in  which  wave  IV  may  form  a  
wave IV– V  complex.  In  such  case,  absence  of  wave  IV  does  not  
indicate  abnormality.  Wave  II  can  be  difficult  to  distinguish  in  some  
normal  subjects.  By  changing  the  stimulus  intensity,   rate  and  phase,  
wave  II  can  be  identified  in  normal  subjects.  Absence  of  all the  waves  ( 
I – V )  is  abnormal.  It  is  also  considered  abnormal,  if  the  wave I  only  is  
recorded  and  the  other  succeeding  waves  are  not  recorded.  Similarly,  
recordable  wave  I  and  III,  but  unrecordable  wave  IV   and  V  is  also  
abnormal.  These  conclusions  are  valid  in  a  technically  satisfactory  
recording,  in  which  the  background  noise  has  been  eliminated.  The  right  
to  left  latency  asymmetry  exceeding  0.5  ms  is  also  abnormal. 
 
 
  
 
 
 
Clinical  neurophysiological  correlation:    
             BAEPs  have  been  correlated  with  different  areas  in  the  brainstem  
auditory  pathways.  Although  the  changes  in  BAEPs  are  non- specific,  
they  provide  information  about  the  function  of  corresponding   auditory  
pathway.  The  abnormalities  of  BAEP  should  therefore  be  correlated  with  
the  clinical  picture  and  other  investigations.   
             Although  the  BAEP  has been studied  in  numerous  neurological  
disorders,  the  most  important  clinical  applications  are  in  cerebellopontine  
angle  tumour,  intrinsic  brainstem  tumour,  multiple  sclerosis,  coma  and  
brain  death 47. 
4.2.2  ESTIMATION OF SERUM  LEVELS OF SUPEROXIDE 
DISMUTASE  
Collection of blood samples  
                   About  5ml of  venous  blood  was  collected  in  a  plain  test  tube 
from each individual  participated  in the study. Blood was  allowed  to  clot  
for  30  min.  at  25o C.  The  blood  was centrifuged  at  2000 x g  for  15  min. 
at 4o C.  The  top  yellow  serum  layer  was  pipetted  out  without  disturbing  
the  white  buffy  layer.  The  serum  was  stored  in  deep  freezer  at  - 80  
degree  Celsius,  till  the  estimation  of  superoxide  dismutase  levels.   
 
  
 
 
 
Estimation   
                   Estimation was done using Superoxide Dismutase kit, Lot Number: 
0471696, Cayman  Chemical  Company,  1180  E.  Ellsworth  Rd.  Ann  Arbor,  
MI  48108. (Refer photograph 2).  
Contents of the kit  
1. Assay  Buffer -  Hypoxanthine  and  DTPA ( Diethylene triamine penta 
acetic acid.  Used  to  dilute  the  radical  detector. 
2. Radical  Detector – Tetrazolium  salt  solution. 
3.Sample  Buffer – Used  to  prepare  the  SOD  standards and  dilute  the  
xanthine  oxidase  and  SOD  samples  prior  to  assaying. 
4. Xanthine Oxidase  
4. SOD Standard  
5. Sample Diluent  
 Principle  
The function of Superoxide dismutase (SOD) is to catalyse  the 
dismutation of the toxic superoxide radical to hydrogen peroxide and molecular 
oxygen. This  method  utilizes   a  tetrazolium  salt  for  detection  of  
superoxide  radicals  generated  by  hypoxanthine  and  xanthine  oxidase  
which  react  with  tetrazolium  to  form  a  red formazan  dye.  One  unit  of  
  
 
 
 
SOD is  defined  as  the  amount  of  enzyme  needed  to  exhibit  50%  
dismutation  of  the  superoxide  radical. The  SOD assay  measures  all  three 
types  of    SOD (Cu/Zn, Mn and FeSOD).  This  method  provides  a  simple,  
reproducible  and  fast  tool  for  assaying  SOD  activity  in  serum. 
Scheme   of   the  Superoxide  dismutase  Assay : 
   
Xanthine + O2                                                           2O2                                                   Formazan dye                            
                          Xanthine       oxidase 
H2O2 + uric acid                                   2O2. -             Tetrazolium salt 
                                                                    SOD                                                     
                                                        O2 + H2O2 
 
 
 
        
 
                                    
  
 
 
 
                                            5. RESULTS 
           In   this  study,  Brainstem  Auditory  Evoked  Potential  was  recorded  
in  40  vitiligo  individuals  and  compared  with  40  age  and  gender  matched  
healthy  normal  subjects.  BAEPs of  both  the  ears  were  recorded.  Absolute  
and  Inter  Peak  Latencies  were  measured. 
             Statistical  analysis :  The  Data  were  expressed  as  mean + standard  
deviation.  The  variations  in  parameters  between  the  two  groups  were  
tested  using  student  independent  t-test  using  SPSS  software  version  17.  
Statistical  significance  was  tested  using  P  value. 
P  -  Value  <  0.05  -  Significant 
P  -  Value  <  0.01  -  Highly  significant 
              The  mean  age  was  28.7 + 6.92  years,  with  a  range  of  15 to  40  
years in  vitiligo  subjects.  The  mean  age  was  28.45 + 7.32  years,  with  a  
range  of  15  to  40  years  in  the  control  group.   
             Age  wise  distribution  of  the  study  and  control  groups  is  depicted  
in  Table 2  and  Graph 1.  Among  the  vitiligo  subjects,  20%  of  them  were  
in  the  age  group  of  16  -  20 years,  40%  were  in  the  age  group  of  21  -  
30 years  and  the  remaining  40%  were  in  the  age  group  of  31  -  40 years. 
  
 
 
 
            The  mean  duration   of  vitiligo  was  found  to  be  3.57 + 2.11 years,  
with  a  range  of  1  to  10  years.  In  this  study,  24 (60%)  were  female  out  
of  40 vitiligo  subjects  as  depicted  in  Table 3  and  Graph 2.             
             Distribution  of  various  types  of  vitiligo  is  depicted  in  Table 4   
and  Graph 3.  In  our   study,  45%  of  vitiligo  subjects  had  vulgaris  type  ;  
25%  of  them  had  acrofacial  type  ;  20%  had  segmental  type  of  
distribution  and  10%  had  focal  type  of  vitiligo. 
            The mean  level  of  absolute  wave  latency  III  of  left  ear  of  vitiligo  
individuals  was  significantly  prolonged  when  compared  to  that  of  the  
normal  healthy  controls  as  depicted  in  Table 5  and  Graph 4. 
           The mean  level  of  absolute  wave  latency  III  of  right  ear  of  
vitiligo  individuals was prolonged and found to be highly significant when 
compared  to  that  of  the  normal  healthy  controls  as  depicted  in  Table 7  
and  Graph 6. 
             The mean  level of Inter  peak  latency  I -  III  of  left  ear  of vitiligo  
individuals was prolonged and found to be highly significant  when  compared  
to  that  of  the  normal  healthy  controls  as  depicted  in  Table 6  and             
Graph 5. 
              The mean  level  of    Inter  peak  latency  I -  III  of  right  ear  of  
vitiligo  individuals  was prolonged and found to be highly significant  when  
  
 
 
 
compared  to  that  of  the  normal  healthy  controls  as  depicted  in  Table 8  
and  Graph 7. 
                 In  this  study,  there  was  a  decrease  in  the   mean  level  of  
serum  superoxide   dismutase  enzyme   in  the  vitiligo  subjects, when  
compared  with  that  of  the  normal   healthy  controls  as  depicted  in  Table 
9  and  Graph 8.  However,  this  was  not  statistically  significant.                                          
       
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 Table 2 :  Age  wise  distribution  of  vitiligo  individuals  and  controls 
Age  in  
years 
Vitiligo 
individuals – 
n 
% Controls – n % 
16  -  20 8 20 6 15 
21  -  30 16 40 16 40 
31  -  40 16 40 18 45 
Total 40 100 40 100 
 
                                                                                                                                                          
 
                                                 Graph  1                                                                                                      
         Age  wise  distribution  of  vitiligo  individuals  and  controls 
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Table  3 : Gender  distribution  in  vitiligo  individuals  and  control  group 
Gender Vitiligo            
individuals           
n 
% Control  
group 
N 
% 
Male 16 40 17 42.5 
Female 24 60 23 57.5 
Total 40 100 40 100 
 
                                                                                                                                           
 
                                                 Graph  2                                                                         
  
Gender  distribution  in  vitiligo  individuals  and  control  group    
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Table  4 :  Distribution  of  various  types  of  vitiligo  
 
Vitiligo  types Vitiligo 
subjects                 
n = 40 
% 
Vulgaris 18 45 
Acrofacial 10 25 
Segmental 8 20 
Focal 4 10 
                                                                                                  
                                           
 
                                              Graph   3 
                    Distribution  of  various  types  of  vitiligo 
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Table  5 :  Absolute  wave  latencies  of  left  ear  compared  between  
vitiligo   individuals   and  control  group 
 
Absolute  
wave  forms 
                  Absolute  wave  latencies (ms)  
P  value Vitiligo  individuals 
n=40                           
Mean + SD 
Controls                      
n = 40                 
Mean + SD 
I 1.43 + 0.08 1.46 + 0.07 0.37 
II 2.29 + 0.18 2.27 + 0.15 0.57 
III 3.34 + 0.16 3.27 + 0.19 0.01* 
IV 4.20 + 0.19 4.19 + 0.17 0.67 
V 5.11 + 0.13 5.09 + 0.13 0.38 
*P < 0.05 - significant ;  Student  independent  t – test 
                   
Graph 4 : Absolute wave  latencies of  left  ear  compared  between  vitiligo  
individuals   and  control  group   
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Table  6 : Inter  Peak  Latencies  of  left  ear   compared  between  vitiligo  
individuals     and  control  group 
                     
Inter Peak   
Waveforms 
         Inter  Peak  Latencies  ( ms )                                      
P  value 
Vitiligo  individuals 
n=40                           
Mean + SD 
Controls                
n = 40              
Mean + SD 
I – III 1.91 + 0.16 1.77 + 0.17 < 0.001** 
I – V 3.69 + 0.15 3.62 + 0.12 0.06 
III – V 1.78 + 0.19 1.85 + 0.17 0.07 
   ** P < 0.01  highly  significant  ;  Student  independent t - test 
 
                                         Graph  5   
Inter  peak  latencies  of  left  ear   compared  between  vitiligo  individuals 
and  control  group 
0
0.5
1
1.5
2
2.5
3
3.5
4
I - III I - V III - V
1.79
3.57
1.781.64
3.5
1.86
In
te
r 
 P
ea
k
  
L
a
te
n
ci
es
 (
m
s)
Inter  Peak  Waveforms  Left  Ear
cases
controls
  
 
 
 
Table  7 :  Absolute  wave  latencies  of  right  ear  compared  between  
vitiligo  individuals  and  control  group 
 
Absolute  
wave  forms 
                  Absolute  wave  latencies (ms)  
P  value Vitiligo  individuals 
n=40                           
Mean + SD 
Controls                      
n = 40                 
Mean + SD 
I 1.39 + 0.06 1.41 + 0.07 0.19 
II 2.13 + 0.14 2.15 + 0.13 0.69 
III 3.18 + 0.17 3.06 + 0.15 0.001** 
IV 4.04 + 0.14 4.03 + 0.14 0.72 
V 4.97 + 0.13 4.91 + 0.15 0.09 
** P < 0.01  highly  significant ; Student  independent  test 
                     
Graph 6 : Absolute  wave  latencies  of  right  ear  compared  between  
vitiligo  individuals  and  control  group 
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Table  8 :  Inter  Peak  Latencies  of  right  ear  compared  between  vitiligo  
individuals   and  control  group 
                     
Inter Peak   
Waveforms 
         Inter  Peak  Latencies  ( ms )                                      
P  value 
Vitiligo  individuals 
n=40                           
Mean + SD 
Controls                
n = 40              
Mean + SD 
I – III 1.79 + 0.17 1.64 + 0.16 < 0.001** 
I – V 3.57 + 0.16 3.50 + 0.18 0.06 
III – V 1.78 + 0.21 1.86 + 0.20 0.117 
   ** P < 0.01  highly  significant  ;  Student  independent t - test 
 
                                                  Graph  7   
Inter  peak  latencies  of  right  ear  compared  between  vitiligo  
individuals and  control  group 
0
0.5
1
1.5
2
2.5
3
3.5
4
I - III I - V III - V
1.79
3.57
1.781.64
3.5
1.86
In
te
r 
 P
ea
k
  
L
a
te
n
ci
es
 (
m
s)
Inter  Peak  Waveforms  Left  Ear
cases
controls
  
 
 
 
Table  9 :  Comparison  of  serum  Superoxide  dismutase  enzyme  levels  
between   vitiligo   individuals  and  control  group 
Group    SOD                         
Mean + SD in U/ml 
P  value 
vitiligo  
individuals   
5.40 + 2.9                       
   0.2 
 
Controls 6.19 + 3.04 
P > 0.05 not  significant ; Student  independent  t – test 
 
 
 
                                                          Graph 8     
Comparison  of  serum  Superoxide  dismutase  enzyme  levels  between   
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                                            6.DISCUSSION 
6.1 CHARACTERISTICS   OF  THE  STUDY  SUBJECTS 
                   The  mean  age  of  vitiligo  subjects  included  in  the  study  was  
28.7 + 6.92 years,  who  ranged  from  15  to  40  years.  The  mean  age  of  
vitiligo  subjects  in  the study  by  Aydogan  K. et al, 2005  was  35.9 + 12.1 
years,  in  the  study  by  Arican  O. et al, 2008,   it  was   24.9 + 18.6  years  
and  the  mean  age  was  33.32  years  in  the  study  by  Sravani  P. V. et al, 
2009,     
                   The  mean  duration  of  vitiligo  among  the  study  subjects  was                      
3.57 + 2.11 years,  in  the  range  between  1  to  10  years, whereas  the  mean              
duration  of  vitiligo  in  the  study  by  Arican  O. et  al, 2008,  was   4.1 + 7.3  
years.  Sravani  P. V.  et  al, 2009  observed  the  mean  duration  of  11.3 years  
in  his  study  subjects.  
6.2  BRAINSTEM  EVOKED  RESPONSE  AUDIOMETRY 
                     Brainstem Auditory  Evoked  Potential ( BAEP ) is  the  surface  
recording  of  the  endogenous  electrical activity of  the  underlying  brain  
structure   ( auditory  pathway )  resulting  from  a  stimulus  bound  activity.  
BAEPs  assess  the  conduction  of  the  impulse  through  the  auditory  
pathway  upto  the  midbrain.  A  brief  auditory  stimulation  generates  action  
potentials  in  the  auditory  pathway.  This  technique  has  been  found  to  be  
relatively  simple,  safe  and  non  invasive  to  implement. The  present  study  
  
 
 
 
was  carried  out  to  record  the  early  changes  that  occur  in  the  eighth  
cranial  nerve  due  to  vitiligo. The  wave  latency  reflects  the  duration  of  
evaluation  process  for  an  event  or  a  stimulus.  
 The  study  in  normal  subjects  showed  that  BAEP  is  a  reliable  method  
and  that  latencies  and  waveforms  are  constant.  This  reliability  depends  
on  a  few  important  factors  maintained  during  the  study,  which  include  
stimulus  frequency  and  intensity,  position  of  electrodes,  auditory  threshold  
level  and  laboratory  temperature 46.  
                      The  functions  of  melanocytes  or  melanin  in  melanocytes  are  
not  clearly  known.  Melanocytes  are  present  in  stria  vascularis,  vestibular  
organ,  endolymphatic  sac  of  the  inner  ear  and  auditory  receptors  or  hair  
cells 2,60. Melanocytes  also  play  a  role  in  the  development  of  
endocochlear  potentials  and  development  of  the  ion  and  fluid  gradient  
between  the  endolymph  and  the  perilymph,  which  are  critical  for  hair-
cell  survival.  Reduced  levels  and / or  reduced  activity  of  pigment  cells  
may  cause  audiological  abnormalities 7,62,63. It  has  been  reported  that  
melanin  has  semi conductive  properties,  responding  to  acoustic,  electrical  
and  phonic  stimulation  and  has  the  ability  to  convert  energy  states  into  
molecular  rotation  and  vibration  as  well  the  reverse  process 61.  The  inner-
ear  melanin  functions  as  an  intracellular  calcium  buffer  and  a  depot  of  
essential  metal  ions that  control  metabolic  processes  and  the  activity  of  
various  enzymes 60-64. In  fact,  a  few  studies  have  shown  that  there  were  
  
 
 
 
some  abnormalities  of  BERA  reported  in vitiligo 10,12,49.  Different  results  
have  been  reported  like  decrease  in  Absolute  latency  of  wave I,  increase  
in  absolute  latency  of  wave III, wave V  and  an  increase  in  Inter  Peak  
Latency  I – III   in  various  studies  of  BERA  in  vitiligo. 
                        The  main  parameters  studied   in  BERA are Absolute  wave  
latencies and  Inter  Peak  Latencies.  Hence  in  our  study,  absolute  wave  
latencies I, II,  III,  IV  and  V  and  inter  peak  latencies  I – III,  I – V  and  III 
– V  between  the  study  group  and  control  group  were  studied. 
6.2.1  Absolute  Wave  Latencies  of  left  ear: 
                     A  significant  ( P < 0.05 )  increase  in  the  absolute  wave  
latency  III  of  left  ear  was  observed  in  vitiligo  subjects  with  the  mean  
value  of  3.34 + 0.16 ms,  when  compared  with  that  of  the  controls,  who  
had  their  mean  value of  3.27 + 0.19 ms  as  depicted  in  Table  5,  Graph  4.  
Similar  results  were  observed  by  Aydogan  et  al,  2005 . 
                The  prolonged  Absolute  wave   latency  III  may  be  due  to  the  
abnormality  in  synaptic  activity  and  transmission  of  action  potential  from  
the  auditory  nerve  to  the  cochlear  nucleus  and   from  the  cochlear  
nucleus  to  the  supraoptic  nucleus  and  inferior  colliculus.  Hence,  vitiligo  
may  be  associated  with  delay  in  synchronization  of  action  potentials  in  
these  nuclei. 
 
  
 
 
 
 6.2.2  Absolute  Wave  Latencies  of  right  ear: 
                     A  statistically  significant  ( P < 0.01 )  increase  in  the  Absolute  
wave  latency  III  of  right  ear  was  observed  in  vitiligo  subjects  with  the  
mean  value  of  3.18 + 0.17 ms  when  compared  with  that  of  the  controls  
who  had  mean  value  3.06 + 0.15 ms  as  depicted  in  Table  7,  Graph  6.  
Similar  results  were  observed  by  Aydogan  et  al,  2005 . 
                The  delay  in  synchronization  of  action  potentials  in  the  auditory  
pathway  could  be  the  explanation  for  this  prolongation  in  the  Absolute  
wave  latency  III.  
6.2.3  Inter  Peak  Latencies  of  left  ear: 
                     A  statistically  significant  ( P < 0.01 )  increase  in  the  Inter  
Peak  Latency I - III ( IPL I – III )  of  left  ear  was  observed  in  vitiligo  
subjects  with  the  mean  values  of  1.91 + 0.16  ms,  when  compared  with  
that  of  the  controls  who  had  1.77  + 0.17 ms  as  depicted  in Table  6,  
Graph  5.  Aydogan  et  al,  2005  observed  similar  results   in  their  study.  
                   In  studies  performed  by  Bassiouny  et  al,  1998  and  Nikifordis   
et  al,  1993,  there  was  prolonged  inter  peak  latency  I – III  in  the  vitiligo  
subjects  when  compared  with  that  of  the  controls.  The  increase  in  IPL I 
– III,  in  their  study  was  due  to  decrease  in  Absolute  wave I latency, 
which  may  be  due  to  the  decrease  in  the  number  of  active  melanocytes  
  
 
 
 
in  the  inner  ear. This  could  have  caused  the  impairment  of  ionic  
exchange  between  perilymph  and  endolymph. 
 6.2.4  Inter  Peak  Latencies  of  right  ear: 
                     A  statistically  significant  ( P < 0.01 )  increase  in  the  Inter  
Peak  Latency  I - III ( IPL I – III )  of  right  ear  was  observed  in  vitiligo  
subjects  with  the  mean  values  of  1.79  + 0.17 ms,  when  compared  with  
that  of  the  controls  who  had  1.64  + 0.16 ms  as  depicted  in  Table  8,  
Graph  7.  
         Prolonged  IPL I – III  was  also  observed  in  studies  done   by  
Aydogan  et  al.  2005,   Bassiouny  et  al.  1998,  and  Nikifordis   et  al. 1993.  
                   Ozuer  et  al.  1998,  and  Shalaby  et  al.  2006,  have  observed  no    
significant  difference  in  the  Absolute  wave  latencies  and  the  Inter  Peak  
Latencies  in  the  BERA  between  the  vitiligo  subjects  and  the  controls. 
                    The  prolonged  Inter  Peak  Latency  I – III  in  both  the  right   
and  left  ear  suggests  that  this  may  be  due  to  the  abnormality  in  synaptic  
activity  and  transmission  of  action  potential  from  the  auditory  nerve  to  
the  cochlear  nucleus  and   from  the  cochlear  nucleus  to  the  supraoptic  
nucleus  and  inferior  colliculus.  Hence,  vitiligo  may  be  associated  with  
delay  in  synchronization  of  action  potentials  in  these  nuclei  and  hence  in  
the  auditory  pathway. 
  
 
 
 
6.3  SUPEROXIDE  DISMUTASE  ENZYME  LEVELS 
               There  was  a  decrease  in  the  serum   level  of  superoxide  
dismutase  enzyme  in  the  vitiligo  subjects,  with  the  mean  value  5.40 + 2.9 
U / ml  (Range : 2.6 – 12 U/ml)  when  compared  to  that of  the  controls, with  
the  mean  value  of  6.19 + 3.04  ( Range : 2.8 – 11.3 U/ml)  as  depicted  in  
Table  9,  Graph  8.  However,  this  was  not  statistically  significant. 
                Several  studies were  done  on  the  various  biomarkers  such  as  
superoxide  dismutase (SOD),  catalase (CAT),  glutathione  peroxidase (GPx)  
and  nitric  oxide (NO)  in  the  vitiligo  subjects.  Different results  were  
reported  about  the  levels  of  these  biomarkers.       
                 Yildirim  et  al.  2004,  Damma  et  al.  2009  and  Sravani  et  al.  
2009,  observed  high  levels  of  superoxide  dismutase  and  glutathione  
peroxidase   and  low  levels  of  catalase 53,54,55  in  the  vitiligo  subjects  when  
compared  with  that  of  the  controls. 
                   Koca et al.  2004  and  Akrem  et  al  2009  reported  low  levels  of  
superoxide  dismutase,  catalase  and  glutathione  peroxidise  in  the  vitiligo  
patients  when  compared  with  that  of  the  controls 56,57. 
                   Picardo et al. 1994 and  Passi  et  al.  1998  found  no  difference  in  
blood  levels  of  superoxide  dismutase,  glutathione  peroxidise,  
lipoperoxidase,  vitamin  E  and  ubiquinone  between  vitiligo  subjects  and  
controls 58,59. 
  
 
 
 
                    Jalel A. et al.  2009  studied   oxidative  stress  in  experimental  
vitiligo mice  and  reported  that  the  generalised  oxidative  stress  played a  
role  in  the  pathogenesis  of  vitiligo.  Plasma  levels  of  malondialdehyde  
were  significantly  higher  ( P < 0.001 )  than  that  of  the  controls.  
Superoxide  dismutase,  Catalase  and  Glutathione  peroxidase  levels  were  
significantly  lower  than  that  of  the  controls. 
                    Several studies suggest that the accumulation of free radicals, 
which  are  toxic to melanocytes may lead to their destruction. The  inherent  
capacity  of  cells  to  withstand  the  oxidative  stress  is  due  to  their  ability  
to  repair  oxidatively  modified  biomolecules,  their  antioxidant  ability  and  
their  capacity  to  sustain   metabolic   requirements   by   deriving   energy   
from  alternate   pathways.   
  
 
                        
 
 
 
 
  
 
 
 
                                              7. CONCLUSION                                                          
                        From  the  present  study,  it  can  be concluded  that  there  is  a  
conduction  delay  in  the  auditory  pathway  in  individuals  with  vitiligo,  as  
evidenced by abnormality  in  Brainstem  Auditory  Evoked  Potential  latency  
parameters. 
                        Melanin  may  play  a  significant  role  in  the  establishment  
and / or  maintenance  of  the  structure  and  function  of  the  auditory  system. 
It may also  modulate  the  transduction  of  the  auditory  stimuli  by  the  inner  
ear.  Melanin  containing  cells  in  the  inner  ear  may  have  a  protective  
function  and  melanin  was  reported  to  play  a  role  in  calcium  homeostasis  
of the endolymph. 
                        Brainstem  Evoked  Response  Audiometry (BERA)  is  a  
simple  and  non-invasive  procedure  which  may  be  done  in  the  vitiligo  
subjects  to  provide  an  early  insight  about  the  probable  involvement  of  
the  eighth  cranial  nerve and the brainstem auditory pathway. Since  the  
BERA  findings  were  abnormal  in  clinically  asymptomatic  vitiligo  
individuals,  this  test  can  be  included  in  the  periodical  follow  up  of  
vitiligo  subjects  for  early  detection  of  subclinical  audiological  
involvement. 
                        The other objective of  this  study  was  to  evaluate  the  role  of  
oxidative  stress  in  the  pathogenesis  of  vitiligo,  by  estimating  serum  
superoxide  dismutase  enzyme  level. Superoxide  dismutase  enzyme  
  
 
 
 
catalyzes  the  conversion   of  superoxide  anions  to  oxygen  and  hydrogen  
peroxide.  It  protects  the  cells  from  the  toxic  effects  of  superoxide  
radicals. The  accumulation  of  free  radicals  which  are  toxic  to  the  
melanocytes,  depends  on  the  inherent  ability  of  the  cells  to  withstand  the  
oxidative  stress. 
                        There  was  a  decrease  in  the  serum  level  of  superoxide  
dismutase  enzyme   in  the  vitiligo  subjects  when  compared  with  that  of  
the  controls. This confirms the imbalance of the oxidant / anti-oxidant systems 
in vitiligo. However,  further  studies  on  a  larger  population   are  needed  to  
substantiate  the  study  results  and  to  stress  the importance  of  antioxidants  
in  reducing  the  oxidative  stress  in  vitiligo  subjects. 
                                                            
 
 
             
  
 
 
 
                       8.  SUMMARY 
 The  purpose  of  this  study  was  to  detect  the  subclinical  
audiological  changes  in  subjects  with  vitiligo.  Since  these  subjects  are  
usually  asymptomatic,  the  abnormal  Brainstem  Evoked  Response  
Audiometry (BERA) changes will  be  of  greater  clinical  significance. 
Forty vitiligo subjects and forty normal subjects participated      in the 
study. Brainstem Evoked Response Audiometry was done for them. The serum  
level  of  Superoxide  dismutase  enzyme   was  also  estimated. 
The  BERA  showed  increase  in  the  Absolute  wave latency   III  and  
Inter  Peak  Latency  I – III  of  both  the  ears  in  the  vitiligo  individuals.  
These  audiological  changes  in  vitiligo  individuals  confirm  that  the  vitiligo  
represents  a  systemic  disease  with  widespread  involvement  of  body  
melanocytes.  Reduced  levels  or  reduced  activities  of  pigment  cells  or  
both  may  be  the  explanation  for  audiological  abnormalities. 
          Also, the decreased antioxidant  level  in  vitiligo   subjects suggests  a  
state  of  oxidative  stress  in  them.  This could be the probable  cause  for  
subclinical  audiological  changes. 
Hence,  Brainstem  Evoked  Response  Audiometry  can  be  included  
in  the  periodical  follow up  of  vitiligo  subjects,  to  detect  early  subclinical  
audiological  involvement  in  them. Further  studies  are  needed  to  
substantiate  the  importance  of  the  antioxidant  therapy  in  the  management  
of  vitiligo  in  addition  to  the  specific  therapies.    
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                                                (ii)  ஒப்புதல் படிவம் 
              
திரு/திருமதி/செல்வன்/செல்வி/_____________________________  
ஆகிய நான் டாக்டர்.xxxxxxxxxxxx பட்டமமற்படிப்புமாணவி, 
உடல் இயங்கியல் துறை, ஸ்டான்லி மருத்துவக் கல்லூரி, 
மருத்துவ- மறையில் நடத்தும் ஆராய்ச்ெியில் யாருறடய 
வற்புறுத்தலும் இன்ைி என்னுறடய முழுெம்மதத்துடன் 
பங்மகற்க ெம்மதம் சதரிவிக்கிமைன். இந்த ஆராய்ச்ெி, மதால் 
நிைமிகளின் குறை- பாட்டால், செவித்திைன் நரம்புகளில் 
ஏற்படும் விறளவுகறள  அைிந்து சகாள்ள உதவியாக 
இருக்கும் என்பறத நான் அைிந்து சகாண்மடன். 
ஆராய்ச்ெியின் செயல்பாடுகறள ஆராய்ச்ெியாளர் மூலம் 
அைிந்து சகாண்மடன். இந்த ஆராய்ச்ெியில் எந்தவித 
மருந்துகமளா ஊெிகமளா அளிக்கப்படமாட்டாது எைவும் நான் 
இந்த ஆராய்ச்ெியில் இருந்து எந்தவித முன்ைைிவிப்புமின்ைி 
விலகிக்சகாள்ள எைக்கு உரிறம உண்டு எைவும் இந்த 
ஆராய்ச்ெியின் ஏடுகள் இரகெியமாக றவக்கப்படும் 
என்பறதயும் நான் அைிமவன். 
மததி :                                                                                                
                                      
                                                ஆய்வில் பங்மகற்பவர் றகசயாப்பம் 
                                                              அல்லது சபருவிரல் பதிவு 
                                                       
 
 
  
 
 
 
 
                                          (ii)  CONSENT FORM 
  
  I  Mr/Mrs/Ms    ______________________________________   
understand  that  Dr.xxxxxxxxxxxxx a postgraduate student in Stanley 
Medical college and Hospital, Chennai is doing the study on Vitiligo 
individuals and control group. I have been made to understand that the 
test will assess the functioning of my ears. The test is simple, involve 
recording of nerve conduction in the ears. They do not involve injections 
or taking any medicines and are risk free. I have been familiarised with 
the testing procedures. I am participating in this study willingly. I have 
not been forced to do so. I have also been told clearly that I could 
withdraw from this study without any prejudice. 
 
Date :                                                                                                                     
                                             
 
                                                                                                
                                     Signature of the participant / Thumb impression 
                                                   
                                               
 
 
 
 
 
                                       
  
 
 
 
                                         (iii)   PROFORMA 
Proforma for the study subject                                      Date : 
1. Sl. No. : 
2. I.D. No.(given by investigator) :                                   Address & Contact 
No. 
3. Name :                                        Ht. 
4. Age :                                            Wt. 
5. Gender :                                     Religion : 
6. Dermatology Dept. No. /  Master Health checkup No. : 
7. Occupation : Not working/  Housewife/ labourer – what type of   
Work / Professionals/ Others (specify ) 
8. Family History : Vitiligo/ Endocrine disorder/ Others 
                                 Parent / Siblings affected 
9. Personal History : Diabetes mellitus/ Thyroid disorder 
10. Past History : Head injury/ Chronic noise exposure 
11. Treatment History : Oral drugs / Parenteral 
                                       Topical agents 
12. Depigmented skin lesions :  Duration  
                                                   Site of distribution 
                                                   Focal/ Segmental/ Vulgaris/ Acrofacial 
13. Hearing impairment : Yes/ No 
14. General Examination : Alert/ Anaemia/ Jaundice/ Cyanosis/ Clubbing 
15. Vital signs : Temp.:           / Pulse rate :             / Blood pressure 
16.  Systemic Examination : Cardiovascular system : 
                                               Respiratory system : 
  
 
 
 
                                               Abdomen :                                                                                             
                                               Central Nervous system : 
17. Local Examination : Depigmented skin lesions  
 
 
 
 18. Ear, Nose , Throat  examination : 
  Audiological Examination : 
1. Examination of the external auditory meatus 
2. Examination of the tympanic membrane 
3. Tuning fork tests 
              a) Rinnie test: 
              b) Weber test: 
4. Pure tone audiometry 
               a) Right ear: 
               b) Left ear: 
5. Brainstem Auditory Evoked Response: 
 Variables (ms) Left  Ear Right  Ear 
Wave Latency I     
Wave Latency II     
Wave Latency III     
Wave Latency IV     
Wave Latency V     
Inter Peak Wave Latency  
I-III     
  
 
 
 
Inter Peak Wave Latency  
I-V     
Inter Peak Wave Latency  
III-V     
 
 
 
 
 
 
 
Cases 
No. Age sex Types
Heigh
t
Weig
ht BMI SOD
Vitiligo yrs F,AF,S,Vcm kg RL1 RL2 RL3 RL4 RL5 RIPL 1-5 RIPL 1-3 RIPL 3-5LL1 LL2 LL3 LL4 LL5 LIPL 1-5 LIPL 1-3 LIPL 3-5 U/ml
1 22 M AF 162 65 24.8 1.42 2.08 3.4 4.1 4.9 3.38 1.78 1.5 1.52 2.35 3.4 4.22 5.03 3.51 1.88 1.63 7
2 31 F V 150 65 28.9 1.5 2.5 3.2 4 4.8 3.28 1.52 1.6 1.5 2.22 3.3 4.35 5.1 3.6 1.8 1.8 4.5
3 34 M V 161 70 27 1.45 2 3.1 4.1 4.62 3.33 1.57 1.52 1.35 2.2 3.3 4.28 5.3 3.95 1.95 2 3.5
4 16 F S 152 48 20.8 1.47 2.28 3.4 4 5.08 3.56 1.73 1.68 1.55 2.62 3.55 4.3 5.2 3.65 2 1.65 4.2
5 24 M AF 163 62 23.5 1.4 2.52 3.2 4.28 4.9 3.02 1.61 1.7 1.46 2.68 3.3 4.3 4.9 3.44 1.84 1.6 6
6 18 M S 160 68 26.6 1.48 2.1 3.1 4.1 4.6 3.02 1.5 1.5 1.4 2.1 3.4 4.3 4.9 3.5 2 1.5 3.5
7 19 F F 151 45 19.7 1.4 2.08 3.45 4.02 4.85 3.42 1.92 1.4 1.4 2.4 3.65 4.3 5.28 3.86 2.23 1.63 6.5
8 16 M S 165 63 23.1 1.5 2 3.2 3.82 4.87 3.3 1.5 1.67 1.4 2.22 3.32 3.98 5 3.6 1.92 1.68 5
9 21 M AF 167 68 24.4 1.3 2.22 3.3 4.38 4.78 3.7 1.9 1.48 1.48 2.42 3.68 4.5 5.28 3.8 2.2 1.6 2.6
10 32 F V 152 60 26 1.4 2.17 3.5 4 4.95 3.8 2 1.45 1.58 2.32 3.8 4.63 5.3 3.72 2.22 1.5 6.4
11 23 F S 152 65 28.1 1.3 2.48 3.38 4.2 5 3.6 2.1 1.62 1.38 2.45 3.65 4.1 5 3.62 2.27 1.35 3.3
12 40 F V 150 65 28.9 1.4 2.15 3.02 4.03 4.9 3.6 1.6 1.88 1.45 2.25 3.25 4.1 5 3.55 1.8 1.75 4.9
13 20 M S 165 70 25.7 1.5 1.9 3.1 4 5 3.4 1.7 1.9 1.42 2.55 3.4 4.37 5.1 3.68 1.98 1.7 12
14 31 F V 161 68 26.2 1.33 2.08 3.18 4.22 4.97 3.67 1.77 1.79 1.35 2.38 3.32 4.6 5.3 3.95 1.97 1.98 5.6
15 40 F V 158 65 26 1.3 2.22 3.28 3.92 4.98 3.7 1.7 1.7 1.4 2.22 3.42 4.3 5.2 3.8 2.02 1.78 3.7
16 23 F AF 157 58 23.5 1.5 2.32 3.5 4.3 5 3.6 1.8 1.5 1.48 2.52 3.48 4.5 5 3.52 2 1.52 6.7
17 31 F V 152 65 28.1 1.47 2.2 3.2 4.1 5 3.53 1.53 1.8 1.6 2.5 3.2 4.2 5 3.4 1.6 1.8 3.4
18 34 F F 156 64 26.3 1.4 2 3.3 4.4 5 3.6 1.8 1.7 1.3 2.2 3.4 4.5 5 3.7 2.1 1.6 5
19 34 F V 155 70 29.1 1.5 2.2 3.4 4.2 5.1 3.4 1.7 1.7 1.3 2.5 3.3 4.1 5 3.7 2 1.7 3.5
20 36 F V 153 65 27.8 1.5 2.2 3.3 4 4.8 3.2 1.7 1.5 1.5 2.4 3.3 4.2 5 3.5 1.8 1.7 4
21 28 M AF 168 75 26.6 1.4 2 3.2 3.8 4.9 3.3 1.6 1.7 1.6 2.5 3.3 4 5.1 3.5 1.7 1.8 4.3
22 40 F V 165 66 24.2 1.38 2 2.8 3.8 4.9 3.42 1.52 2.1 1.3 2.3 3.2 4 5 3.7 1.9 1.8 4
23 37 M V 175 70 22.9 1.3 2.2 3.3 4 5 3.6 1.7 1.7 1.5 2.3 3.3 4 5 3.5 1.8 1.7 14
24 30 M V 168 75 26.6 1.4 2.1 3 4 5 3.4 1.5 2 1.43 2.2 3.3 4 5.1 3.67 1.87 1.8 8
25 30 M F 165 66 24.2 1.5 2.1 3.2 4 4.9 3.5 1.5 1.7 1.43 2.2 3.4 4.2 5.3 3.87 1.97 1.9 6.9
26 29 M AF 165 60 22 1.3 2.1 3.1 4 5.1 3.7 1.7 2 1.4 2.1 3.1 4.1 5.3 3.9 1.7 2.2 5
27 36 F V  155 52 21.6 1.4 2 3.2 3.9 5 3.5 1.7 1.8 1.5 2.2 3.3 4 5 3.5 1.8 1.7 3.9
28 28 M V 165 66 24.2 1.5 2 3.1 4 5 3.4 1.5 1.9 1.4 2.4 3 3.9 5.1 3.7 1.6 2.1 3.6
29 23 F AF 153 65 27.8 1.5 2 3 4 5 3.5 1.4 2 1.4 2 3.1 4 5.1 3.7 1.7 2 3.6
30 22 F S 155 52 21.6 1.4 2.1 2.8 3.8 4.8 3.5 1.3 2 1.4 2 3.1 4.1 5.2 3.8 1.7 2.1 3
31 19 M S 168 60 21.3 1.46 2 3 4 5.1 3.54 1.44 2.1 1.4 2.2 3.3 3.9 5.2 3.8 1.9 1.9 2.7
32 27 F AF 158 70 28 1.48 2 3 4 5.1 3.62 1.52 2.1 1.3 2.1 3.2 4.2 5.1 3.8 1.9 1.9 6.1
33 33 F V 153 65 27.8 1.3 2.1 3 3.9 5.1 3.7 1.6 2.1 1.3 2 3.2 4.1 5.2 3.9 1.9 2 11.7
34 36 F V 155 70 29.1 1.5 2.2 3.2 4 5.1 3.5 1.6 1.9 1.5 2.2 3.4 4.2 5.1 3.6 1.9 1.7 4.6
35 31 M S 173 80 26.7 1.4 2.2 3.2 4.1 5.1 3.7 1.7 1.9 1.36 2.5 3.3 4.3 5.3 3.94 1.94 2 4.9
36 26 F F 152 52 22.5 1.3 2 3.2 4 5.2 3.7 1.6 2 1.36 2.1 3.4 4.2 5 3.64 2.04 1.6 11
37 40 M V 172 74 25 1.3 2.2 3.2 4.1 5 3.6 1.7 1.8 1.4 2.2 3.4 4.5 5 3.6 2 1.6 3.6
38 29 F AF 158 70 28 1.4 2.2 3.1 4 5.1 3.6 1.6 2 1.42 2.3 3.4 4.2 5.2 3.78 1.98 1.8 3.9
39 32 F V 152 60 26 1.38 2 3 4 5.1 3.62 1.52 2.1 1.38 2 3.2 4.1 5.3 3.92 1.82 2.1 3.1
40 27 F AF 154 60 25.3 1.4 2.1 3.2 4 5.1 3.5 1.6 1.9 1.42 2.2 3.2 4 5.1 3.68 1.78 1.9 4.1
                                                                             Right Ear                                                                                                       Left Ear
ControlsAge Sex HeightWeightBMI SOD)
     No. yrs cm kg RL1 RL2 RL3 RL4 RL5 RIPL 1-5RIPL 1-3 RIPL 3-5 LL1 LL2 LL3 LL4 LL5 LIPL 1-5 LIPL 1-3 LIPL 3-5 U/ml
1 29 M 172 70 23.7 1.42 2.05 3.2 4 4.8 3.38 1.78 1.6 1.55 2.2 3.38 4.35 5.18 3.63 1.83 1.8 4
2 35 F 163 58 21.8 1.5 2.22 3.02 4 4.78 3.28 1.52 1.76 1.52 2.3 3.4 4.2 5.2 3.68 1.88 1.8 4
3 29 F 169 52 18.2 1.45 1.98 3.02 4.05 4.78 3.33 1.57 1.76 1.45 2.1 3.22 4.4 5.3 3.85 1.77 2.08 6.2
4 29 M 168 64 22.7 1.47 2.2 3.2 4 5.03 3.56 1.73 1.83 1.6 2.4 3.45 4.3 5.32 3.72 1.85 1.87 5
5 33 F 168 58 20.5 1.4 2.48 3.01 4.03 4.42 3.02 1.61 1.41 1.48 2.5 3.3 4.2 4.88 3.4 1.82 1.58 5
6 27 F 164 70 26 1.48 2 2.98 4.03 4.5 3.02 1.5 1.52 1.5 2.1 3.3 4.28 4.9 3.4 1.8 1.6 9
7 40 F 158 65 26 1.4 2.17 3.32 3.92 4.82 3.42 1.92 1.5 1.42 2.35 3.6 4.4 5.2 3.78 2.18 1.6 8
8 27 F 154 52 21.9 1.5 2 3 3.9 4.8 3.3 1.5 1.8 1.4 2.3 3.2 4.1 5 3.6 1.8 1.8 3.5
9 25 F 156 64 26.3 1.3 2.2 3.2 4.2 5 3.7 1.9 1.8 1.45 2.3 3.6 4.5 5.2 3.75 2.15 1.6 3.8
10 36 M 173 70 23.4 1.4 2.2 3.4 4.2 5.2 3.8 2 1.8 1.6 2.4 3.7 4.6 5.4 3.8 2.1 1.7 4.2
11 29 F 163 62 23.5 1.3 2.5 3.4 4.1 4.9 3.6 2.1 1.5 1.4 2.4 3.6 4.2 5 3.6 2.2 1.4 4.2
12 32 F 165 63 23.1 1.4 2.2 3 4.1 5 3.6 1.6 2 1.5 2.3 3.3 4.2 5.2 3.7 1.8 1.9 4.3
13 40 M 175 70 22.9 1.5 2.1 3.2 4.1 4.9 3.4 1.7 1.7 1.5 2.2 3.3 4.2 5 3.5 1.8 1.7 3.6
14 37 M 168 75 26.6 1.33 2.1 3.1 4.2 5 3.67 1.77 1.9 1.4 2.2 3.2 4.5 5.2 3.8 1.9 1.9 4.9
15 40 M 172 80 27 1.3 2 3 4.1 5 3.7 1.7 2 1.4 2.2 3.2 4.3 5.1 3.7 1.8 1.9 9
16 26 F 161 68 26.2 1.5 2.4 3.3 4.2 5.1 3.6 1.8 1.8 1.5 2.6 3.4 4.3 5.2 3.7 1.9 1.8 5.8
17 18 F 152 54 23.4 1.47 2.1 3 4.2 5 3.53 1.53 2 1.6 2.5 3.4 4.3 5.1 3.5 1.8 1.7 6.9
18 40 F 150 65 28.9 1.4 2.2 3.2 4.5 5 3.6 1.8 1.8 1.47 2.4 3.3 4.4 5.1 3.63 1.83 1.8 10.7
19 34 M 169 80 28 1.5 2.4 3.2 4 4.9 3.4 1.7 1.7 1.48 2.6 3.4 4.3 5.2 3.72 1.92 1.8 6.4
20 20 M 168 58 20.5 1.5 2.1 3.2 4 4.7 3.2 1.7 1.5 1.6 2.4 3.2 4.3 5 3.4 1.6 1.8 4.2
21 17 F 154 52 21.9 1.4 2.1 3 3.7 4.7 3.3 1.6 1.7 1.4 2.2 3 3.9 5 3.6 1.6 2 5.5
22 19 F 153 50 21.4 1.38 2.1 2.9 3.8 4.8 3.42 1.52 1.9 1.39 2.2 3.1 4 4.8 3.41 1.71 1.7 8.8
23 24 M 168 75 26.6 1.3 2.2 3 4 4.9 3.6 1.7 1.9 1.4 2.3 3.2 4.1 4.9 3.5 1.8 1.7 6.4
24 29 M 172 74 25 1.4 2 2.9 3.9 4.8 3.4 1.5 1.9 1.41 2.1 3 3.9 5 3.59 1.59 2 7
25 33 M 168 60 21.3 1.5 2.2 3 4 5 3.5 1.5 2 1.42 2.1 3.2 4.1 5.1 3.68 1.78 1.9 11.3
26 23 F 155 52 21.6 1.3 2.1 3 4.1 5 3.7 1.7 2 1.39 2.2 3 4.2 5.1 3.71 1.61 2.1 14
27 18 M 165 60 22 1.4 2.2 3.1 4 4.9 3.5 1.7 1.8 1.43 2.3 3.2 4.1 5 3.57 1.77 1.8 4.6
28 16 M 158 55 22 1.5 2 3 3.9 4.9 3.4 1.5 1.9 1.5 2 3 4 5 3.5 1.5 2 5.7
29 21 M 160 52 20.3 1.5 2.1 2.9 4 5 3.5 1.4 2.1 1.51 2.1 3.2 4.1 5.2 3.69 1.69 2 7
30 28 F 150 58 25.8 1.4 2 2.7 4 4.9 3.5 1.3 2.2 1.46 2.1 2.9 4 5 3.54 1.44 2.1 4.9
31 20 M 168 75 26.6 1.46 2 2.9 3.9 5 3.54 1.44 2.1 1.48 2.1 3 4 5 3.52 1.52 2 7
32 28 M 165 66 24.2 1.48 2.1 3 4.1 5.1 3.62 1.52 2.1 1.5 2.2 3.2 4.2 5.2 3.7 1.7 2 15.6
33 34 F 160 75 29.3 1.3 2 2.9 3.8 5 3.7 1.6 2.1 1.4 2 3.1 4 5.1 3.7 1.7 2 5.6
34 31 M 161 70 27 1.5 2.2 3.1 4.1 5 3.5 1.6 1.9 1.5 2.3 3.2 4.1 5.1 3.6 1.7 1.9 6.6
35 36 F 156 64 26.3 1.4 2.1 3.1 4 5.1 3.7 1.7 2 1.4 2.2 3.1 4.1 5.2 3.8 1.7 2.1 5.8
36 34 F 154 52 21.9 1.3 2 2.9 4 5 3.7 1.6 2.1 1.39 2.1 3 4 4.9 3.51 1.61 1.9 3.3
37 23 F 158 70 28 1.3 2.2 3 4 4.9 3.6 1.7 1.9 1.4 2.4 3.2 4.1 5 3.6 1.8 1.8 3
38 18 F 155 52 21.6 1.4 2.3 3 4.1 5 3.6 1.6 2 1.4 2.5 3.3 4.2 5.1 3.7 1.6 1.8 2.8
39 21 F 158 55 22 1.38 2.1 2.9 4 5 3.62 1.52 2.1 1.4 2.2 3 4 5.2 3.8 1.6 2.2 3.9
40 39 F 158 70 28 1.4 2.2 3 3.9 4.9 3.5 1.6 1.9 1.42 2.3 3.1 4 5 3.58 1.68 1.9 4
                                                                            Right Ear                                                                                                                           Left Ear
  
 
 
 
      
 
 
 
